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Abstract  
State of the art  Depressive disorders are fairly prevalent in the general 
population, with a higher rate in women compared to men,  are disabling, 
since they can significantly impair psychosocial functioning, and are 
typically associated with high mortality due mainly to the high rate of 
suicides but also to the negative impact that depression has on the course 
of co-occurring illnesses. In addition, pharmacological and psychological 
antidepressant therapies in use have a limited efficacy and/or are 
associated with side effects that reduce the compliance in many patients. 
Although the etiology and pathogenesis of depression are poorly 
understood, it is most likely that the combination of genetics, early life 
adverse events, and ongoing stress may ultimately determine the 
individual vulnerability to stress-related disorders, such as depression. 
Therefore, the development and characterization of animal models of 
vulnerability and resistance to the effects of stress, including early life 
stress, is a major challenge for depression research.  
One such model is represented by the Roman high- (RHA) and low-
avoidance (RLA) lines/strains of rats, which are psychogenetically 
selected for, respectively, rapid versus extremely poor acquisition of 
active avoidance in a shuttle box. A large body of evidence indicates that 
a major reason for their divergent performance in this test is their different 
reactivity to stressful stimuli, that is, their coping style. Thus, when 
exposed to aversive stimuli, RLA rats display a reactive coping strategy, 
associated with a strong activation of the HPA axis; moreover, they 
display robust depressive-like behaviors in the forced swim test (FST) 
that are normalized by the subacute administration of antidepressants. In 
contrast, compared with their RLA counterparts, RHA rats display a 
proactive coping strategy in the face of aversive conditions, associated 
with higher baseline levels of impulsivity, a more robust 
sensation/novelty seeking profile, a marked preference for, and intake of, 
natural and drug rewards along with a greater responsiveness of the 
mesolimbic dopaminergic system.  
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Aims  The behavioral and neurochemical traits that distinguish the two 
lines/strains suggest that RLA rats may represent a model of vulnerability 
to stress-induced depression, whereas RHA rats may model resistance to 
stress-induced depression-like behaviour.  
To test this hypothesis, in the first study we evaluated the performance of 
RLA and RHA rats in the FST in response to chronic antidepressant 
treatments, since clinical evidence indicates that several weeks of 
treatment with antidepressant drugs are required to achieve an adequate 
therapeutic response. 
Furthermore, one of the cardinal symptoms of depression observed in 
many patients is anhedonia, which is defined as the loss of interest in 
once enjoyable activities, including sexual activity. Accordingly, 
depressive episodes are frequently associated with sexual dysfunctions. In 
consideration of this clinical evidence, and given the well-established role 
of dopamine in sexual behavior, the second study was aimed at 
characterizing the sexual behavior of RHA and RLA rats and its 
correlation with the functional state of their mesolimbic dopaminergic 
system. 
In keeping with the long-term consequences on mental health elicited by 
early-life adverse events, it has been observed that post weaning social 
isolation in rodents may lead to a later increment in the prevalence of 
anxiety/fear related behaviors. Thus, in the third study we evaluated the 
impact of post weaning isolation on the anxiety-related behaviors of 
inbred RHA and RLA rats in the Elevated Zero Maze, and in motility 
cages used to asssess locomotor activity in a new environment. 
  
Results  In study I we demonstrated that chronic treatments with low 
doses of antidepressants, that were ineffective when given subacutely, 
were able to decrease immobility and also to increase climbing 
(desipramine) or swimming (fluoxetine) in RLA rats. Conversely, neither 
subacute nor chronic antidepressant treatments affected the behavior of 
RHA rats in the FST. 
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In addition, the results of study II showed that, compared with their RLA 
counterparts, RHA rats displayed higher levels of sexual motivation and a 
better copulatory performance, associated with a greater release of DA in 
the AcbSh.  These line-related differences were attenuated but not 
abolished by sexual experience. Moreover, RLA rats were more 
responsive than their RHA counterparts to both, the facilitatory effect of 
apomorphine and the inhibitory effect of haloperidol on sexual behavior. 
Finally, in study III we found that the isolation-rearing procedure 
significantly increased the level of anxiety of RHA-I rats in the EZM, as 
reflected by a smaller number of entries and a shorter time spent in the 
open space, associated with decreased head dipping, increased latency to 
enter in the open space, and reduced novelty-induced locomotor 
activation, whereas it failed to produce significant changes in the behavior 
of RLA-I rats. 
 
Conclusions  The results of these studies show that the Roman 
lines/strains of rats may represent a valid experimental approach to 
investigate the neural substrates and molecular mechanisms involved in 
the individual vulnerability and resistance to stress-induced depression, 
with the aim of identifying both, potential biomarkers for an early 
diagnosis of depression and potential molecular targets for novel 
antidepressant treatments. Moreover, the Roman lines/strains may be used 
to study the neurophysiology of the appetitive and consummatory aspects 
of sexual behaviour, in order to better understand the mechanisms 
underlying the psychological and pathological causes of sexual 
dysfunctions. Finally, the Roman rats may provide a useful model to 
identify the mechanisms whereby early-life adverse events interact with 
the genetic make up to induce psychiatric disorders in adulthood. 
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1.1 Depression: diagnosis and social impact 
 
Depression is a psychiatric condition belonging to the category of mood 
disorders. Notably, mood is not the only aspect that is dysregulated in this 
complex illness, since also neurovegetative, psychomotor and cognitive 
functions are impaired in depressed patients. Mood disorders are 
classified by the Diagnostic Statistical Manual-V (DSM-V) of mental 
disorders [1] into two major categories: 
 Major Depressive Disorder (MDD) or 'unipolar' depression, 
characterized by only depressive episodes; 
 Bipolar disorder, previously termed Manic-Depressive illness, 
when the extremely low mood typical of depressive episodes 
alternates with states of excessive euphoria typical of mania. 
 
Each of these forms of mood disorders includes several subtypes that 
differ mainly for the severity, frequency and duration of the symptoms. 
As regards depressive disorders, the cardinal symptoms identified by the 
DSM-V include:   
 
 Persistent depressed mood more days than not for at least two 
weeks; 
 Feelings of hopelessness, worthlessness and excessive or 
immotivate guilt; 
 Anhedonia (i.e., loss of interest in once pleasurable activities, 
including sex); 
 Fatigue and decreased energy; 
 Psychomotor agitation or retardation; 
 Appetite increment or loss; 
 Insomnia or excessive sleeping; 
 Difficulty concentrating, remembering, making decisions; 
 Recurring thoughts of suicide. 
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The simultaneous presence of 5 or more of these symptoms, experienced 
most of the day nearly every day for at least two weeks, with a severity 
that compromises the daily life of the affected individual, justifies the 
diagnosis of Major Depressive Disorder (MDD). Milder cases are 
classified as “dysthymia,” although there is no clear distinction between 
the two [2]. 
Another distinction that should be done is based on the etiology of the 
disorder. In this context, the DSM-V identifies two types of mood 
disorders: Mood Disorder Due to a General Medical Condition and 
Substance-Induced Mood Disorder. The former is diagnosed when the 
mood disturbance is judged to be the direct physiological consequence of 
a specific general medical condition (e.g., multiple sclerosis, stroke, 
hypothyroidism); the latter when a substance (e.g., a drug of abuse, a 
medication, or exposure to a toxin) appears to be etiologically related to 
the mood disturbance. 
 
This differential diagnosis may be not easy because depression can be 
either the consequence or the cause of another illness,  or even the two 
illnesses may simply co-exist without etiological relationship. Among the 
most common medical conditions or illnesses that co-occur with 
depression, we can consider anxiety disorders and substance (especially 
alcohol) abuse, but also other serious diseases such as diabetes, AIDS, 
heart disease, cancer and Parkinson's disease. There is evidence that 
patients affected by chronic illnesses have a higher risk for depression 
than the general population. Similarly, depressed patients present 
substantial rates of comorbidity with chronic medical diseases [3]. For 
this reason, in case of co-existence of depression and another illness, an 
early diagnosis of both conditions assumes a great importance for a better 
treatment. 
 
Comorbidity is only one of the aspects that contributes in rendering 
depression a significant public health issue. Depressive disorders and 
especially MDD are fairly prevalent in the general population, with a 
higher rate in women compared to men, are disabling, since they can 
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significantly impair psychosocial functioning, and are typically associated 
with  high mortality due mainly to the high rate of suicides but also to the 
negative impact that depression has on the course of co-occurring 
illnesses.  
In addition, depression does not discriminate on account of age: it can 
arise in childhood, adolescence, adulthood and even in elderly, albeit with 
differences in the variety of symptoms. Furthermore, antidepressant 
(pharmacological and psychological) therapies in use have a limited 
efficacy and/or are associated with side effects that reduce the compliance 
in many patients.  
 
Hence, the study of the neurobiological mechanisms underlying 
depressive disorders is extremely important in order to develop more 
effective strategies for their prevention and treatment. 
 
 
1.2 The neurochemistry of depression 
 
1.2.1 The monoamine hypothesis 
Among the several neurochemical hypotheses formulated to explain the 
etiology and pathogenesis of depression, the monoaminergic hypothesis is 
the one that has received most attention. This hypothesis was proposed in 
1965 by Schildkraut, who asserted that depression is associated with a 
deficiency of monoamine activity at important sites in the brain, whereas 
mania is associated with a relative excess [4]. 
 
This hypothesis derives from the observation that reserpine, a drug used 
as an antihypertensive, induces severe depressive symptoms. The 
antihypertensive effect of reserpine is due to its ability to prevent the 
storage of norepinephrine (NE), dopamine (DA) and serotonin (5-HT) 
into the synaptic vesicles thereby leading to their accumulation in the 
cytosol where they are converted into inactive metabolites by the 
monoamineoxidases (MAOs). 
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Other events that contributed to support the monoaminergic hypothesis 
were the serendipitous discoveries that the potential antitubercular 
iproniazid [5, 6] and the potential antipsychotic imipramine [7] could 
relieve many symptoms of depression. Thus, iproniazid and imipramine 
became the founders of two classes of antidepressants: the MAO-
Inhibitors (MAO-I) and the Tricyclic antidepressants (TCA), respectively. 
They both increase the availability of monoamines (mainly NE), MAO-Is 
by inhibiting their catabolic enzyme, and TCAs by blocking their 
reuptake into presynaptic neuron terminals [8].  
 
These first antidepressants were not selective for NE or 5-HT and they 
produced an increment in the levels of many other neurotransmitters, even 
not catecholaminergic, provoking a series of side effects. Much effort was 
devoted over the following years to the development of selective 
antidepressants, such as the NRIs (Norepinephrine Reuptake Inhibitors) 
and the SSRIs (Selective Serotonin Reuptake Inhibitors).  
NE is well known to play a major role in the control of neuroendocrine 
activity, in the mechanisms of reward, attention and stress-response, all of 
which are altered in mood disorders. Similarly, the influence of serotonin 
on emotivity, thermoregulation, food intake, sleep and nociception, is 
accountable for its involvement in the pathophysiology of depression and 
explains the therapeutic success attained by SSRIs.  
 
1.2.2 The role of dopamine 
Another important monoaminergic neurotransmitter to take into account, 
is dopamine (DA). Although DA has not received as much attention as 
serotonin and norepinephrine in the pathophysiology of depression, 
several lines of evidence support the involvement of the dopaminergic 
system in depression: 
 the concentration of homovanillic acid (HVA), a major metabolite 
of dopamine, is decreased in the cerebrospinal fluid (CSF) of 
depressed patients [9-13]; 
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 prominent symptoms of depression may precede, or co-exist with, 
Parkinson's disease (which affects the nigrostriatal dopaminergic 
system) [14, 15]; 
 psychostimulants (which are known to elevate DA concentrations 
in the mesolimbic circuitry) induce euphoria and increased energy 
in depressed and euthymic individuals [16, 17]; 
 inhibitors of DA reuptake, like bupropion, are effective 
antidepressants [18]; 
 dopamine antagonists are able to elicit depression-like symptoms 
[19].  
 
In this context, it is well established that the mesocortical and mesolimbic 
dopaminergic systems are critically involved in the mechanisms of 
aversion and motivation/gratification. In particular, the dopaminergic 
neurons originating in the ventral tegmental area (VTA) and projecting, 
among others, to the nucleus accumbens (Acb), amygdala (AMYG) and 
prefrontal cortex (PFCx), are able to react to stimuli with a certain 
motivational value. 
The limbic system allows the individual to recognize those natural 
rewarding stimuli that are essential for the survival of the species, such as 
food and  sexual activity. The mesolimbic dopaminergic system is also 
activated by addictive drugs; however, at variance with natural rewards, 
the activation induced by drug reward is much stronger because it does 
not undergo habituation. The activation of the mesolimbic dopaminergic 
system in response to consummatory behaviors associated with feelings 
of pleasure and satisfaction, suggests that a hypofunction of this system 
may reduce the ability to appreciate pleasurable activities thereby leading 
to anhedonia and lack of motivation which are two cardinal symptoms of 
depression [18]. 
 
As already mentioned, also aversive stimuli are able to activate the 
mesocortical and mesolimbic dopaminergic systems. In particular, the 
mesocortical projections respond to mild aversive stimuli [20, 21], while 
stronger and longer-lasting stressors are required to activate the 
mesolimbic system [22, 23]. 
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Moreover, the mesocortical system is involved in the control of cognitive 
processes. Therefore, an alteration of this system may contribute to the 
cognitive deficits observed in depressed patients, such as the reduction of 
attention and ability to concentrate and memorize [1]. 
 
Finally, since DA is involved in the control of motor activity, it has been 
proposed that a dopaminergic hypofunction may be involved in the 
psychomotor retardation observed in some depressed patients [19]. 
 
Even though the monoamines are the neurotransmitters that have been 
most extensively studied in relation to the pathophysiology of depression 
and represent the principal target of the currently used antidepressant 
drugs, other neurotransmitters cannot be ruled out, given the complexity 
of the depressive syndrome that implies an interaction among different 
neurotransmitters and also between neurotransmitters and endocrine 
systems. 
 
1.2.3 The glucocorticoid hypothesis 
Beyond the hypotheses concerning the function of different 
neurotransmitters in the pathophysiology of depression, there are other 
hypotheses that take into account the role of the neuroendocrine systems.  
One of such hypotheses assigns a fundamental role to the hypothalamic-
pituituary-adrenal (HPA) axis, which is intensely activated by acute and 
chronic stress [2]. 
Thus, many neurotransmitters, such as NE, 5-HT, acetylcholine (Ach) and 
γ-aminobutiric acid (GABA), modulate the secretion of corticotropin-
releasing factor (CRF) by the neurons of the hypothalamic paraventricular 
nucleus (PVN) in response to stress. CRF stimulates the anterior pituitary 
to produce and release adrenocorticotropin (ACTH) which, in turn, 
stimulates the synthesis and release of glucocorticoids (cortisol in 
humans, corticosterone in rodents) from the adrenal cortex. 
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Glucocorticoids have profound effects on both, general metabolism and 
behavior that are necessary to tackle the adverse situation, like the 
consumption of energy and the promotion of certain cognitive abilities 
[2]. Normally, glucocorticoids exert an inhibitory feedback, via the 
hippocampus, on the HPA axis thereby ensuring a transitory activation of  
this cascade. However, in conditions of severe and/or prolonged stress, 
the levels of glucocorticoids remain high and the hippocampal neurons 
are not able to inhibit their release [24]. 
 
Fig.1 Regulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis. CRF-
containing parvocellular neurons of the paraventricular nucleus of the hypothalamus 
(PVN) integrate information relevant to stress. Prominent neural inputs include 
excitatory afferents from the amygdala and inhibitory (polysynaptic) afferents from the 
hippocampus. Other important inputs are from ascending monoamine pathways (not 
shown). CRF is released by these neurons into the hypophyseal portal system and acts on 
the corticotrophs of the anterior pituitary to release ACTH. ACTH reaches the adrenal 
cortex via the bloodstream, where it stimulates the release of glucocorticoids. In addition 
to its many functions, glucocorticoids (including synthetic forms such as 
dexamethasone) repress CRF and ACTH synthesis and release. In this manner, 
glucocorticoids inhibit their own synthesis. At higher levels, glucocorticoids also impair, 
and may even damage, the hippocampus, which could initiate and maintain a 
hypercortisolemic state related to some cases of depression. [2] 
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Several studies have demonstrated that in a large percentage of 
symptomatic depressed patients the plasmatic concentration of cortisol is 
persistently higher with respect to healthy controls. Moreover, in these 
individuals the administration of dexamethasone (a synthetic analog of 
cortisol) does not suppress the release of cortisol induced by CRF, 
suggesting that the regulation of the HPA axis activity through the 
negative feedback is altered. Finally, the intracerebral administration of 
CRF in experimental animals produces effects that are similar to those 
observed in humans, such as a reduction in locomotor activity, loss of 
appetite, insomnia and anxiety. These preclinical and clinical findings 
suggest a correlation between the hyperactivity of the HPA axis and 
depression [25]. 
 
The mechanisms by which sustained high levels of glucorticoids are able 
to alter the inhibitory feedback on the HPA axis are not yet completely 
understood but in vitro studies have revealed a damage of hippocampal 
neurons which involves a reduction in dendritic branching and a loss of 
highly specialized dendritic spines important for the reception of 
glutamatergic synaptic inputs [26, 27]. Moreover, the damage triggers a 
positive feedback because the reduction in the inhibitory control exerted 
by the hippocampus on the HPA axis leads to a further increase in 
circulating glucocorticoid levels and subsequent hippocampal damage [2]. 
 
The results of studies aimed at characterizing the pathologic effects of 
stress on the hippocampus have led to another recent hypothesis that 
proposes a role for neurotrophic factors in the etiology of depression and 
in its treatment [28, 29]. 
 
1.2.4 The neurotrophic factor hypothesis and the role of 
BDNF 
Neurotrophic factors are so named because they were first characterized 
as peptides involved in the modulation of neural growth and 
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differentiation during development, but now they are known to be 
required also for plasticity and survival of adult neurons and glia [2]. The 
neurotrophin family includes nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), neurotrophin-3, and neurotrophin 4/5. 
Although all of these neurotrophins are expressed throughout the central 
nervous system, the most widely distributed and most abundant in the 
brain is BDNF.  
BDNF is synthesized as a precursor protein known as prepro-BDNF that 
is cleaved into pro-BDNF, which can then be further cleaved into mature 
BDNF [30]. Recent data suggest that pro-BDNF and mature BDNF 
activate different intracellular signaling pathways [31-33]. Pro-BDNF 
signals through the low-affinity neurotrophin receptor p75 that is believed 
to be involved in apoptosis [30, 34], whereas mature BDNF signals 
through its high-affinity tropomyosin related kinase B (TrkB) receptor 
[35]. When BDNF is bound to TrkB, it induces its dimerization and the 
receptor tyrosine kinase is autophosphorylated, leading to the activation 
of intracellular signaling cascades, as well as augmentation of N-methyl-
D-aspartate (NMDA) receptor-mediated currents [36].  
The BDNF-TrkB activation can regulate at least three signaling 
transduction pathways (Fig. 2): (i) the phospholipase Cγ (PLCγ) pathway, 
which leads to activation of protein kinase C; (ii) the phosphatidylinositol 
3-kinase (PI3K) pathway, which activates serine/threonine kinase AKT; 
and (iii)  the mitogen-activated protein kinase [MAPK, or extracellular 
signal related kinase (ERK)] pathway, which activates several 
downstream effectors. Each of these signaling pathways mediates the 
unique functions of BDNF on cells (for review, see [37, 38]). Briefly, 
rapid synaptic and ion channel effects are thought to depend on PLCγ-
mediated release of intracellular calcium stores, and longer-lasting 
genomic effects are considered to be downstream of PI3K and MAPK 
pathways. In addition, there is also evidence that BDNF may directly 
activate voltage-gated sodium channels to mediate rapid depolarization of 
target neurons [39]. 
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Fig.2 BDNF signaling through TrkB receptors All three pathways converge on 
transcription factor CREB (cAMP response element-binding protein), which can up-
regulate gene expression. CaM: calmodulin; CaMK: calmoduline kinase; DAG: 
diacylglicerol. [35] 
 
There are several lines of preclinical and clinical evidence supporting a 
role for BDNF in depression and in the mechanisms of action of 
antidepressants. 
Clinical studies in depressed patients have revealed decreased plasma 
levels of BDNF, a condition that is normalized by antidepressant 
treatments [40, 41]. However, it is not clear if the plasma levels of BDNF 
are indicative of its cerebral concentration. Additional clinical evidence 
derived from post-mortem investigations comparing depressed patients 
without treatment (i.e., suicide victims or with other causes of death) with 
depressed patients that were good responders to antidepressants. The 
results of those studies show that in not treated patients there are low 
concentrations of BDNF and TrkB in the hippocampus (HIPP) and 
prefrontal cortex (PFCx) [42, 43], and even a reduced hippocampal 
volume [35]. Conversely, patients successfully treated with 
antidepressants show an increase in the hippocampal and cortical 
concentrations of BDNF and TrkB [44]. 
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In keeping with the results obtained in humans, several preclinical studies 
have been perfomed in a variety of animal models of depression, in which 
the depressive-like behavior can be the result of a genetic selection or it 
can be induced by environmental or pharmacological manipulations 
during the development or in adulthood [45]. 
In particular, the results of preclinical studies show that: 
 chronic mild stress or unpredictable stress can lead to decreases in 
hippocampal mRNA and protein levels of BDNF in mice and rats 
[44]; 
 similarly, long-term administration of corticosterone is sufficient to 
produce decreases in BDNF expression in the rat hippocampus [46]; 
 in contrast, chronic and subacute treatment with antidepressants 
increases the  expression of BDNF in the hippocampus [47, 48]. 
Moreover, electroconvulsive stimuli increase the concentrations of 
BDNF in the hippocampus, striatum, and occipital cortex [49]; 
 infusion of BDNF into the midbrain, ventricles, or hippocampal 
regions results in increased antidepressant-like behavior [50-53]. In 
particular, Siuciak and collaborators have demonstrated that the 
infusion of BDNF into the midbrain produces antidepressant-like 
effects in learned helplessness paradigms and in the forced swim test 
[54].  
Altogether, these results support the hypothesis that the concentrations of 
BDNF in the hippocampus may be correlated with both, the appearance 
of depressive symptoms and their resolution with antidepressant 
treatments. It is noteworthy, however, that other neurotrophic factors and 
brain areas may also be involved. 
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1.2.5 Beyond the hippocampus 
Neuroimaging studies in patients with the diagnosis of major depressive 
disorder have identified structural and functional abnormalities in the 
orbital and dorsal PFCx, the amygdala, and related parts of the striatum 
and thalamus. These abnormalities, which can be permanent or reversible, 
include changes in the volume, in the cerebral blood flow (CBF) and in 
glucose metabolism of the involved brain area. Accordingly, post mortem 
studies demonstrate reductions in orbital and medial PFCx volume even 
in the brain of patients who died during symptom remission. Conversely, 
changes in physiological activity (CBF and glucose metabolism) are 
mood state-dependent and generally normalize with antidepressant drug 
treatment [55].  
In particular, a decreased CBF and metabolism have been observed 
during depressive episodes in dorsal PFCx areas implicated in language, 
selective attention, visuospatial or mnemonic processing [55]. 
Conversely, in the ventrolateral, orbital and pregenual anterior cingulate 
portions of the PFCx abnormal elevations of CBF and metabolism have 
been recorded [56-58]. The activation of the posterior orbital cortex is 
thought to reflect endogenous attempts to break persevering patterns of 
negative thoughts and emotions which may be driven by pathological 
limbic activity involving the amygdala [57]. Regarding the amygdala, 
regional CBF and glucose metabolism consistently correlate positively 
with depression severity [59-61], but this abnormally elevated activity 
decreases toward normal levels during antidepressant drug treatment [62]. 
The amygdala participates in the assignment of emotional significance to 
experimental stimuli and in the organization of behavioral, autonomic, 
and neuroendocrine manifestations of emotional expression [63]. In 
particular, during depressive episodes, the metabolic rate of the amygdala 
is positively correlated with plasma cortisol concentrations, suggesting 
that pathological amygdala activity may increase HPA axis activity in 
depression [64].  
 
Collectively, these results support a neural model of depression in which 
dysfunctions involving brain regions that modulate or inhibit emotional 
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behavior may lead to the emotional, motivational, cognitive, and 
behavioral manifestations of mood disorders. 
 
 
1.3 Animal models of depression 
 
Animal models remain indispensable tools for the advancement of 
medicine as a whole, and for psychiatry in particular. It is most important 
to keep in mind that the use of animals in medical research must be based 
on ethical principles, which can be summarized by the so called "rule of 3 
Rs": 
 Reduction: researchers should use the lowest number of animals 
sufficient to guarantee statistic reliability). This objective may be 
met by improving experimental techniques and sharing 
information among researchers; 
 Refinement: it is necessary to refine the experiment or the way 
the animals are taken care for so as to minimize their suffering; 
 Replacement: when possible, experiments with animals should be 
replaced with alternative techniques. 
 
Ideally, the animal model created should mimic the human condition of 
interest with respect to its etiology/biological basis (construct validity), 
symptomatology (face validity) and response to treatment (predictive 
validity) [65]. 
Clearly, meeting such requirements is difficult, especially for depression, 
since many of the core symptoms of this disorder (e.g., feelings of 
worthlessness, guilt and suicidal ideation) cannot be modeled in an 
animal. Furthermore, the multifactorial pathogenesis of depression does 
not allow an easy creation of animal models with a good construct 
validity. Nevertheless, since depression is often described as an abnormal 
reaction to stress, most models have exposed healthy animals to adverse 
experiences for prolonged periods of time in order to induce a depressive-
like phenotype. 
 
15 
 
 
A clear example of model based on stress-response is the chronic mild 
stress (CMS) paradigm. In the CMS the animal is exposed to a series of 
different unpredictable stressful conditions, such as mild unescapable foot 
shock, changes in housing conditions, food and water deprivation, 
reversal of light/dark periods, and exposure to noise and bright light. 
After exposure to these stressors for 2 or 3 weeks, rats show a number of 
behavioral changes that are maintained for months and are reminiscent of 
depressive symptoms. These include not only changes in psychomotor 
behavior (e.g., reduced open field activity), but also a reduced sensitivity 
to rewards, as evidenced by a decrease in the consumption of sucrose 
solution in comparison to tap water [66]. The strength of the CMS model 
is its predictive validity, because long-term treatment with various 
antidepressants causes a return to initial levels of sucrose intake [67, 68]. 
 
Another kind of stressor is represented by early maternal separation, in 
which the pups are separated from their mothers for brief periods of time, 
every day, during the first weeks of their life. Given the important role 
played by the close contact with the dam in the emotional and cognitive 
development of the offspring, early maternal separation results in a 
traumatic event that causes acute disturbances and produces long-lasting 
effects. These effects, including the repeated activation of stress 
mediators such as glucocorticoids and catecholamines, can influence the 
behavior and neurochemistry over the lifetime of the mammal, leading to 
psychiatric disorders in adulthood [69]. Similarly, it has been observed 
that in humans early stressors such as neglect or abuse lead to persistent 
elevations of CRH, rendering an individual vulnerable to depression or 
anxiety, or both [67]. 
 
These examples make use of normal rodents (rats or mice) in which the 
behavioral changes bearing a resemblance to depression are induced by 
the stressful experience. Another approach is represented by the olfactory 
bulbectomy. It is based on the observation that the olfactory system in 
the rat forms a part of the limbic region in which the amygdala and 
hippocampus contribute to the emotional and mnemonic components of  
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behavior. These neuroanatomical areas seem to be dysfunctional in the 
patient with major depression. Thus, bilateral olfactory bulbectomy 
causes a major dysfunction of the cortical-hippocampal-amygdala circuit 
leading to changes in behavior, and in the endocrine, immune and 
neurotransmitter systems. These changes resemble many of those seen in 
patients with major depression and are normalized by chronic 
antidepresssant treatments [70]. 
However, none of these models accounts for the genetic vulnerability in 
the development of depression. Genetic factors strongly influence the 
pathogenesis of this illness (as well as of the majority of illnesses), 
although the gene(s) involved have not yet been identified. The research 
of specific genes is difficult for different reasons. Firstly, depression is a 
complex disorder that involves a large number of genes. In addition, 
epidemiological data underline the existence of a complex relationship 
between genotype and environment. Thus, genetic factors partially 
influence overall risk of illness but also influence the sensitivity of 
individuals to the depression-inducing effects of environmental 
adversities [71]. The combination of genetics, early life stress, and 
ongoing stress may ultimately determine individual responsiveness to 
stress and the vulnerability to psychiatric disorders, such as depression. It 
is likely that genetic factors and life stress contribute not only to the 
neurochemical alterations, but also to the impairments of cellular 
plasticity and resilience observed in depression [72]. 
Considering the pivotal role of genetic factors in the pathogenesis of 
depression, several genetic animal models of depression have been 
developed. Some of these make use of genetically engineered mice, such 
as DAT, NET, and SERT (respectively: Dopamine-, Norepinephrine- and 
Serotonin- Transporter) knockout (KO) mice, to study the contribution of 
specific genes, in particular those encoding for monoamine transporters 
that are the targets of the most widely used antidepressant drugs [73]. 
Other models are based on the use of lines/strains of rats or mice selected 
for their differences in phenotypic characteristics associated (in a more or 
less fortuitous way) to depression.  
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One such model is represented by the Flinders Sensitive Line (FSL) of 
rats. This model was developed at the Flinders University in Australia 
with the purpose of creating a line of rats that was genetically resistant to 
the effects of di-isopropyl-fluoro-phosphate (DFP), an organophosphate 
cholinesterase inhibitor  [74]. However, the selective breeding program 
failed in this aim because the Flinders Resistant Line (FRL) rats are not 
more resistant to DFP relative to outbred control rats but only with 
reference to the FSL rats [75, 76].  Thus, FSL rats are more sensitive to 
DFP and cholinergic agonists than their FRL counterparts. Since 
depressed individuals are more sensitive to cholinergic agonists than 
normal controls, the FSL rats were proposed as an animal model of 
depression [77-79]. Accordingly, this line of rats exhibits some behavioral 
features resembling those seen in depressed patients, such as reduced 
locomotor activity, reduced body weight, increased REM sleep and 
cognitive deficits [80]. This model has been very useful as a screen for 
antidepressants since many depressive-like behaviors (such as the 
immobility in the forced swim test) exhibited by FSL rats are reverted by 
chronic antidepressants, including those without anticholinergic effects 
[81]. However, this model (as well as the majority of animal models) has 
some limitations, such as the inconsistency with other hypotheses about 
the pathophysiology of depression, (e.g., the involvement  of the HPA 
axis) [74]. 
Another genetic model that may provide a valid approach to investigate 
the contribution of the genotype, and its interactions with environmental 
factors, on the neural substrates of depression is represented by the 
Roman High- and Low-Avoidance rats. 
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1.4 The Roman high- and low-avoidance rats 
 
1.4.1 Background 
The Roman high- (RHA) and low-avoidance (RLA) rats were 
psychogenetically selected from a Wistar stock of Rattus Norvegicus for 
rapid (RHA) versus extremely poor (RLA) acquisition of the active 
avoidant behavior in a shuttle box.  
The process of selection started in 1965 in Rome [82] where the first five 
generations were bred, and it was subsequently carried on in Birmingham 
(U.K.) [83]. In 1972, some couples of RHA and RLA rats belonging to 
the 22nd generation, were sent to the Department of Psychology and 
Psychiatry of the University of London, where the study of the genetic 
mechanisms involved in the avoidance response continued for several 
years [84]. In 1972 some of the animals bred in Birmingham were also 
sent to Zurich where the Swiss subcolony was established (i.e., 
RHA/Verh and RLA/Verh) [85]. More recently, breeding nuclei from the 
Swiss colony were used to establish two other colonies, one at the 
Autonomous University of  Barcelona, started in 1993, and the other at 
the University of Cagliari (1998). The rats in the Spanish colony are 
inbred [86], whereas the initial outbreeding process was continued in the 
Italian colony [87]. 
At present three colonies of Roman rats exist: the Swiss colony, which 
was moved from Zurich to Geneva in 1998 [88]; the Spanish colony at the 
Autonomous University of Barcelona and the Italian colony established at 
the Department of Life and Environmental Sciences of the University of 
Cagliari. 
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1.4.2 The selection criterion: Two-way Active Avoidance 
test 
The criterion used to select the Roman high- and low-avoidance rats is 
represented by their behavioral response in the two-way active avoidance 
test. 
Briefly, this test consists of placing the animal in a shuttle box divided in 
two compartments communicating by an opening. The floor of the shuttle 
box is a metallic grid connected to an instrument that provides a tone and 
a light as a conditioned stimulus (CS) followed by an electric shock to the 
paws as unconditioned stimulus (US). These stimuli are always presented 
in the compartment occupied by the rat, so that it has to flee to the safe 
chamber before the onset of the unconditioned stimulus to avoid the 
shock. Such response of the animal is considered as an avoidance, while 
if the rat flees to the safe chamber after the onset of the US, it is 
considered as an escape. Finally, if the animal stays in the same 
compartment during the entire shock, the behavior is called failure.  
As shown in these graphs, the two lines differ markedly in the number of 
avoidances, which is significantly higher in RHA rats as compared with 
RLA rats. Conversely, the number of failures is much higher in RLA than 
RHA rats. 
                   
Fig.3  Performance in the active avoidance test of RHA and RLA rats. Columns and 
bars indicate the mean  S.E.M. of 20 rats per line. *: P<0,0001 vs the corresponding 
value of RHA rats. 
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Although the performance in the two-way active avoidance test is widely 
considered to depend on learning and memory, there is growing evidence 
that other mental processes may modify the ability to acquire the avoidant 
response.  
Actually, the initial phase of the acquisition in the shuttle box seems to 
generate a conflict situation in the animal that affects its ability to learn 
the avoidant behavior. Due to this conflict, the animal shows an emotional 
response called conditioned fear which is responsible for the tendency to 
remain immobile (freezing). Such response prevents the acquisition of the 
active avoidance [89]. Accordingly, it has been demonstrated that 
behavioral [90, 91] and pharmacological [89] manipulations reducing 
fear/anxiety promote avoidance acquisition, whereas other factors, such as 
anxiogenic drugs [89] or environmental conditions that induce 
fear/anxiety have the opposite effect [92]. 
These results validate the use of the active avoidance test to study anxiety 
in rodents [89], as well as the elevated plus-maze test [93], the  conflict 
test [94, 95] and the social interaction test [96]. 
 
1.4.3 Phenotypic characteristics of RHA and RLA rats 
On the basis of the above mentioned findings, it has been proposed that 
the factor that prevents the acquisition of the avoidance response in RLA 
rats is their high emotionality [97] rather than a learning deficit, as 
described also in other low-avoidance strains [98]. 
Not only the RLA rats are not "dumber" than RHA rats, but in several 
learning tests that imply only a marginal or moderate component of stress 
[91, 98-100], as in the case of the Hebb-Williams Maze test [101], RLAs 
perform significantly better than their RHA counterparts.   
Thus, the opposite reactivity to stressful stimuli, defined as coping style 
or coping strategy, displayed by RLA and RHA rats accounts for their 
divergent performance in the active avoidance test and also for many 
other behavioral traits that distinguish the two lines. In particular, in a 
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variety of tests used to assess emotionality and coping styles in rodents, 
the hyperemotional RLA rats show a  reactive coping, with a behavioral 
repertoire characterized by hypomotility and robust self-grooming and 
freezing, while the hypoemotional RHA rats display a proactive coping 
strategy aimed at taking control over the stressor [21, 88, 91, 97, 102-
104]. A divergence in the response to stress is also observed in the 
neuroendocrine function, with RLA rats showing higher activation of the 
hypothalamus-pituitary-adrenal (HPA) axis than RHA rats, as reflected by 
a larger increase in corticotropin and corticosterone secretion following 
exposure to mild stress [88, 105-107]. Moreover, the combination of the 
dexamethasone suppression test (DST) with a corticotropin-releasing 
hormone (CRH) challenge, has shown that RLA rats are more responsive 
to CRH administration than RHA rats [108], as observed in many 
symptomatic depressed patients [25]. 
 
The behavioral and neuroendocrine characteristics of RLA rats described 
above suggest that this rat line may be more prone to develop depression-
like behavior under adverse experimental conditions [108]. On the other 
hand, RHA rats display a number of traits such as low HPA axis 
reactivity and emotionality, high impulsivity and novelty/sensation 
seeking, and proactive coping [21, 88, 100, 102, 109, 110] that may be 
involved in their resistance to undergo stress-induced depression-like 
behavior [111]. 
 
In this context, the performance of  RLA and RHA rats in the Forced 
Swim Test, one of the most widely used methods to examine  depression-
like behavior and to evaluate the efficacy of antidepressant drugs in 
rodents, was evaluated by Piras et al. [111]. Two main findings emerged 
from that study: (i) under baseline conditions RLA rats displayed greater 
immobility and fewer active behaviors than RHA rats, (ii) the subacute 
treatment with antidepressant drugs reduced the immobility and increased 
the active behaviors in RLA rats, leaving the performance of RHA rats 
unaffected.   
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The coping strategy is also correlated with the prefrontal dopaminergic 
function. In this context, it is interesting to note that studies in gerbils 
indicate that a transient increment in dopamine (DA) output in the medial 
prefrontal cortex (mPFCx) is required for the acquisition of the avoidant 
behavior in the shuttle box [112, 113]. Accordingly, in vivo voltammetry 
and microdialysis studies conducted in Roman rats, have shown that a 
variety of stressors activate the mesocortical dopaminergic pathway of  
RHA, but not of RLA, rats [21, 114]. This and other lines of evidence 
support the view that the behavioral patterns that distinguish the Roman 
lines may be mediated, at least in part, by differences in the functional 
properties of their mesotelencephalic dopaminergic projections (see [115] 
and references therein).  
 
The differences between RHA and RLA rats in terms of the functional 
tone of mesocorticolimbic dopaminergic transmission may also account 
for their different responsiveness to a variety of drugs of abuse. Thus, 
intracerebral microdialysis studies have demonstrated that (i) acute 
administration of morphine or psychostimulants determines  a larger 
increment in DA output in the nucleus accumbens shell (AcbSh) of RHA 
rats vs. the AcbSh of RLA rats; (ii) the repeated administration of 
morphine and cocaine elicits behavioral (i.e., enhanced locomotor 
activity) and neurochemical sensitization in RHA, but not RLA rats [87, 
115]. In addition, in self-administration (SA) studies with cocaine it has 
been observed that, compared with their RLA counterparts, RHA rats 
display (I) faster acquisition of the SA behavior; (II) larger amount of 
drug consumed; (III) higher resistance to extinction; (IV) more robust 
drug-induced reinstatement of cocaine-seeking behavior [116]. The 
greater propensity to consume drugs of abuse displayed by RHA vs RLA 
rats, may also be influenced by the high levels of impulsivity [100] shown 
by the former, since it is well known that impulsivity is one of the 
susceptibility factors for the development of drug addiction [117, 118]. 
 
Hence, RHA rats may represent a genetic animal model to study the 
individual vulnerability to undergo a transition from recreational and 
controlled drug use to compulsive and uncontrolled drug abuse. 
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Moreover, RHA rats may also represent a model of resilience to stress-
induced depression, whereas RLA rats, with their low responsiveness to 
natural and drug rewards [87, 109, 116] resembling the anhedonic state of 
depressed patients, may be considered as resistant to drug addiction. 
Nevertheless, it has been shown that RLA rats are able to increase ethanol 
intake to correct for an aversive emotional state induced by incentive loss 
[119]. 
 
The increased behavioural responsiveness to psychostimulants upon 
repeated administration [115, 120, 121], the augmented mesocortical 
dopaminergic response to stress [21], the poor performance in several 
learning/memory tasks not involving electric shocks [101, 122-124] and 
the enhanced impulsive behavior in the 5-choice serial reaction time task 
(5-CSRTT) and DRL-20 operant tasks [99, 100, 125] shown by RHA rats 
suggest that this strain/line of rats model some core symptoms of 
schizophrenia. Considerable experimental evidence supports this view. 
For instance, in inbred Roman rats (RHA-I and RLA-I) it has been 
demonstrated that, compared with the RLA strain and/or with standard rat 
strains, RHAs display deficits in latent inhibition threshold [126], as well 
as in Pre-Pulse Inhibition (PPI), spatial working memory, and reference 
memory [127, 128], resembling the cognitive deficits and sensorimotor 
gating impairments seen in schizophrenic patients. Furthermore, in the 
study of Klein and colleagues [125], RHA-I rats showed no detectable 
expression of mGluR2 in the frontal cortex, hippocampus and striatum 
(for the implications of the mGluR2 in schizophrenia see the review 
[129]). These behavioral and neurochemical characteristics of RHA rats 
are reminiscent of some core features of the schizophrenic phenotype. 
 
 
 
24 
 
1.5 Depression and anhedonia: implications 
for sexual behavior 
 
1.5.1 The biological value of pleasure 
One of the core features of depression is represented by anhedonia, 
which was originally defined as the inability to experience pleasure [130], 
but is now considered to be a wider concept that includes decreased 
motivation to seek, diminished interest in and inability (or reduced 
ability) to concentrate on pleasurable activities [131]. Undoubtedly, 
pleasure is a fundamental factor in the control of motivated behaviors in 
humans and, although the term "pleasure" may be questioned referring to 
rodents, a similar variable may control motivated behaviors also in 
animals. Through motivated behavior, animals (and humans) adapt to 
external or internal changes and reduce their bodily needs that act as 
driving forces. Thus, some drives, such as thirst or hunger, are part of the 
regulatory process of homeostasis and act to correct an internal change 
(the deficit of water or food, respectively). In other conditions the control 
of behavior does not appear to be based on any well-defined physiological 
deprivation but on external triggering stimuli, as in the case of mating or 
exploration, which are respectively driven by sex arousal and curiosity. 
The ability to feel pleasure associated to motivated behaviors, for instance 
in response to food or during sexual activity, is innate since such 
behaviors are fundamental for the survival of the individual and the 
species. This kind of pleasure is connected to the consummatory aspect 
of the motivated behavior that manifests itself with a specific behavioral 
repertoire depending on the nature of the stimulus. However, in a 
motivated behavior the consummatory phase is usually preceded by 
adaptive, flexible forms of appetitive behavior, which enables an animal 
to come into physical contact with its goal. In the appetitive phase, 
pleasure consists in a state of incentive arousal which reinforces the 
seeking of and the approaching to the goal. This "anticipatory" pleasure is 
not innate, but learned, since it implies a classical conditioning in order to 
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associate the predictive stimulus (e.g., the pheromones coming from a 
potential partner) with the possibility to gain the goal (e.g., copulation). 
 
1.5.2 The brain reward circuitry  
The motivational properties of pleasure depend on the activity of 
anatomically and functionally interconnected brain areas that define the 
so-called brain reward circuitry. This circuitry includes limbic structures 
(such as the infralimbic portion of PFCx, the shell of the Acb (AcbSh), 
the medial portion of the ventral pallidum (VP), the AMYG, and the 
VTA) which play a pivotal role in the control of motivated behavior, and 
motor structures (the prelimbic portion of PFCx, the Acb core (AcbCo), 
the dorsal VP and the substantia nigra) which are more relevant for 
habitual behaviors. As previously described, both natural rewarding 
stimuli and drugs of abuse are able to activate this circuitry; in particular, 
they share the ability to induce the release of  dopamine (DA) in the 
AcbSh. More precisely, dopamine release from the nucleus accumbens is 
modulated by various characteristics of the stimulus and by the 
motivational state.  
 
 
 
Fig. 4 Schematic representation of the human brain reward circuitry 
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1.5.3 Reward-related impairments 
A dysfunction in processing rewarding stimuli is characteristic of some 
psychiatric conditions. For instance, in substance abuse disorders there is 
an excessive activation of the mesolimbic dopaminergic system that 
promotes incentive learning, a mechanism by which otherwise 
emotionally neutral stimuli acquire a motivational value. On the contrary, 
in depressive disorders, previously attractive stimuli lose their rewarding 
properties thereby leading to anhedonia. Anhedonia in humans can be 
measured in various ways (for an extensive review see [132]). Behavioral 
[133], electrophysiological [134], hemodynamic [135], interview-based 
measures [136], and self-reports are frequently cited in research related to 
anhedonia in major depressive disorder (MDD) [137]. Such variety of 
measurements is justified by the complex nature of anhedonia, that may 
be defined as a composite symptom, consisting of at least two dimensions 
(i.e. motivational/appetitive and consummatory) [138], each one based on 
distinct biological mechanisms [139]. It is noteworthy in this context that 
depression seems to be characteristically linked to motivational anhedonia 
which has been consistently correlated with mesolimbic dopaminergic 
signalling [138, 139]. 
 
1.5.4 Depression and sexual activity  
The loss of interest in once enjoyable activities (i.e., anhedonia) observed 
in many depressed patients often includes sexual activity. Several studies 
have demonstrated that the prevalence of sexual dysfunction is higher in 
patients with MDD than in the general population [140-147]. Moreover, 
the frequent coexistence with anxiety symptoms, which are also 
associated with sexual problems, can exacerbate this condition [148-153]. 
Depressed persons may experience a series of sexual problems: frequently 
they express a reduction of sexual desire (libido) and excitement 
(arousal), a diminished ability to maintain sexual arousal or achieve 
orgasm, and in males also erectile dysfunction can occur [154]. 
Unfortunately, in addition to ameliorating the majority of depressive 
symptoms, almost all antidepressants fail to improve sexual dysfunction 
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and can actually cause a decrease in libido and other sexual side-effects 
that reduce the compliance of the patient. Notably, an exception is 
represented by bupropion, which increases central dopaminergic 
transmission [155]. In this context, it is noteworthy that dopamine 
transmission in the hypothalamus [156-163] and in the mesolimbic 
projection [164-169] has a facilitatory effect on both the anticipatory 
(sexual motivation/arousal) and the consummatory (penile erection and 
copulation) phases of sexual behaviour in laboratory animals and humans. 
  
Therefore, the study of the neurophysiology of sexual function (in  its 
appetitive and consummatory aspects) is warranted in order to better 
understand the mechanisms underlying the psychopathological and 
pharmacologic causes of sexual dysfunctions. 
 
 
1.6 Early life adverse experiences and 
psychiatric disorders 
 
As mentioned in the section "animal models of depression", the early 
maternal separation paradigm may be used to induce a depression-like 
phenotype in rodents. Thus, such a traumatic event experienced in early 
life may produce long-lasting effects, including the sensitization of the 
HPA axis, which increase the risk to develop anxiety and/or depressive 
disorders in adulthood.   
A large body of preclinical and clinical evidence supports the view that 
exposure to either rewarding or traumatic experiences in early life plays a 
pivotal role in the development of the central nervous system thereby 
influencing the behavior and neurochemistry over the lifetime of the 
individual. Therefore, the exposure to adverse experiences in early-life 
may contribute to the occurrence of psychiatric disorders, such as 
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depression, schizophrenia, and substance abuse in genetically predisposed 
individuals [170-172]. 
Notably, the eventual development of a psychiatric disorder, as well as 
the type of disorder, may be determined not only by the genotype of the 
individual who experiments the adverse event but also by the 
characteristics of the adverse experience. For instance, severe, horrendous 
stress, such as that experienced during combat, does not typically induce 
depression, but instead causes post-traumatic stress disorder (PTSD). 
 
Similarly, different experimental paradigms used to model early life stress 
in laboratory animals may induce differential neurochemical and 
behavioral changes depending on the species, the line/strain and the sex 
of the animal used for the test.   
 
Thus, while early maternal separation has been proposed as a paradigm to 
induce a depression-like phenotype, the role of post weaning social 
isolation appears to be more related to the later development of 
schizophrenia-like symptoms, although some controversial issues remain 
unclear.  
 
It is noteworthy in this context that the Roman lines/strains of rats may 
model the genetic predisposition for depression (RLA), as well as the 
vulnerability to develop schizophrenic or substance abuse disorders 
(RHA). Exposing RLA and RHA rats to adverse early-life events (such as 
maternal separation or social isolation) may therefore contribute to  the 
identification of the molecular mechanisms underlying the long-term 
consequences of adverse early-life events, in order to improve our 
knowledge on the pathogenesis of several psychiatric disorders and to 
identify new targets for their treatment. 
  
 
29 
 
1.7 Objectives 
 
Although exposure to stressful and/or traumatic events, especially in early 
life, is considered to be a major predisposing factor to depression and 
other psychiatric disorders, not all humans exposed to severe stress 
develop a psychopathology. This suggests that the individual sensitivity 
to stress plays a pivotal role in determining vulnerability or resistance to 
depression and other psychiatric disorders. 
Notably, the selective breeding of Roman lines/strains of rats has 
generated two phenotypes that differ markedly in the reactivity to 
stressful stimuli.  
The vulnerability of RLA rats and, viceversa, the resistance of RHA rats 
to develop stress-induced depression, as suggested by their divergent 
behavioral and neurochemical traits, was assessed in a previous study in 
which the performance of the two lines was compared in the Forced 
Swim Test (FST) under baseline conditions and after subacute treatments 
with antidepressant drugs. However, that study showed the positive 
response of RLAs to subacute antidepressants, whereas it is well known 
that several weeks of treatment with antidepressant drugs is required to 
obtain an adequate clinical response.  
On the bases of the results obtained in the study by Piras et al., and 
considering the clinical reports, the aim of study I was to evaluate the 
performance of RLA and RHA rats in the FST in response to chronic 
antidepressant treatments at doses that were ineffective when given 
subacutely.    
One of the cardinal symptoms of depression observed in many patients is 
anhedonia, which may be defined as a loss of interest in once enjoyable 
activities, including sexual activity.  
Depressive episodes are frequently associated with sexual dysfunctions, 
especially concerning the motivational aspects of sexual activity. In 
consideration of this clinical evidence, and given that:  
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 RHA and RLA rats display different coping styles and behavioral 
profiles, including a marked difference in the responsiveness to 
natural and drug rewards; 
 these differences may be determined, at least in part, by different 
functional properties of brain dopaminergic  transmission; 
 dopamine has a well documented facilitatory effect on both, the 
motivational and the consummatory aspects of sexual behavior;  
study II was aimed at characterizing the sexual behavior of Roman 
rats and its correlation with the functional state of the mesolimbic 
dopaminergic transmission. 
Finally, in keeping with the long-term consequences on mental health 
elicited by early-life adverse events, it has been observed that post 
weaning social isolation in rodents may lead to a later increment in the 
anxiety/fear related behaviors  and to other behavioral and neurochemical 
alterations that have translational relevance to developmental 
neuropsychological disorders, in particular to several core symptoms of 
schizophrenia.  
Thus, in study III the impact of an early adverse experience, such as 
the post weaning isolation, on the anxiety-related behaviors of RHA 
and RLA (inbred) rats was evaluated in the Elevated Zero Maze and 
in motility cages used to asssess locomotor activity in a new 
environment.  
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2. Study I: Effects of subacute and 
chronic antidepressant treatments in 
RLA and RHA rats 
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2.1 Introduction 
 
As described in the general introduction, the individual vulnerability to 
depression is determined by a combination of genetic factors, early life 
stress, and ongoing stress, and the relative contribution of each 
component may be studied using animal models. In this context, the 
selective breeding of Roman high- (RHA) and low-(RLA) avoidance rats 
led to the fortuitous segregation of behavioral traits (such as the reactive 
coping associated with hyper-reactivity of the HPA axis shown by RLA 
rats exposed to stressful conditions) that are reminiscent of some key 
features of clinical depression.  
 
Thus, the behavioral traits and neurochemical characteristics that 
distinguish the Roman lines suggest that, under stressful conditions, RLA 
rats may be prone, whereas RHA rats may be resistant to develop 
depression-like behavior. To test this hypothesis, the performance of these 
rat lines was evaluated by  Piras et al. [111] in the Forced Swim Test 
(FST), a paradigm used to evaluate depression-like behavior and to assess 
antidepressant activity in rodents [173-175]. It was found that RLA rats 
remained immobile for a longer time and spent less time in active 
behaviors than RHA rats, either during the 15-min pre-swim session or 
during the 5-min swim test performed 24 h later. Moreover, subacute 
treatments with clinically effective antidepressants, such as desipramine, 
fluoxetine, and chlorimipramine, produced a dose-dependent decrease in 
immobility and an increase in active behaviors in  RLA rats, but did not 
modify the performance of RHA rats [111]. 
 
Because clinical studies consistently show that several weeks of drug 
administration are required to observe the first improvements in the 
depressive symptoms, the present study was designed to further evaluate 
the responses to antidepressants of RLA and RHA rats by comparing the 
effects of subacute (1 day) and chronic (15 days) administration of 
desipramine, fluoxetine, and chlorimipramine on their performance in the 
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forced swim test. To this aim, antidepressant drugs were administered 
chronically at doses that were ineffective when given subacutely and 
passive and active behaviors were assessed during a single exposure to 
the swim test, that is without pretest [176]. 
 
 
2.2 Materials and methods 
 
2.2.1 Animals 
A total number of 229 male rats (115 RHA and 114 RLA) bred in the 
colony established in 1998 at the University of Cagliari were used. The 
rats were 4-month old at the time of behavioral testing (body weight 400–
500 g). After weaning at postnatal day 25, they were housed in groups of 
four per cage and were maintained in a temperature- and humidity 
controlled environment (23±1 °C and 60 %, respectively) under a 12-h 
light–dark cycle (lights on at 8:00 a.m.), with standard laboratory food 
and water freely available. To minimize stress to the rats before the test, 
the contact with the  animal house maintenance personnel was limited to a 
single attendant, and bedding in the home cages was not changed in the 
two days preceding the test. All the procedures were performed in the 
housing facilities of the Department of Life and Environmental Sciences 
of the University of Cagliari, in accordance with the guidelines and 
protocols approved by the European Union (EU Council 86/609; D.L. 
27.01. 1992, no.116) and by the Ethical Committee for Animal Care and 
Use of the University of Cagliari. 
 
2.2.2 Forced Swim Test  
The Forced Swim test (FST), described originally by Porsolt et al. [173, 
177], consists of placing the animal in an inescapable deep tank of water, 
since it has been observed that in such condition rats and mice develop 
immobility after an initial period of vigorous activity [173]. The reduction 
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of escape-directed behavior (such as swimming or climbing) is thought to 
resemble the inability to adopt proactive coping strategies under stressful 
situations, which is a core feature of human depression [178]. 
Antidepressant treatments reduce the amount of immobility, or delay its 
onset, and increase or prolong active escape behaviors displayed during 
the FST [178].  
 
The procedure used in our study was very similar to that described by 
Porsolt et al. [173] and modified by Detke et al. [174], except that the 
water was deeper to ensure that rats were unable to touch the bottom of 
the cylinder with their hind paws or tail. Swim sessions were conducted 
by placing the rats in individual plastic cylinders 58 cm tall and 32 cm in 
diameter which were filled with water (24–25°C) to a height of 40 cm 
from the bottom (for more details see [111]).  
 
The usual paradigm implies a first exposure to inescapable swim for 15 
min (pre swim session) which serves as an induction procedure that 
facilitates passive behaviors on subsequent swim exposure, and is 
followed, 24 h later, by a 5-min swim test during which the active and 
passive behaviors displayed by the rats are recorded [175]. However, in 
this study only the 5-min swim test, without the pre swim session, was 
performed in order to compare more equally the effects of subacute and 
chronic treatments. 
 
2.2.3 Behavioral measurements 
A single well-trained observer, blind to the treatment condition, 
quantified all the behaviors using a time-sampling technique whereby the 
predominant behavior in each 5 s period of the test was recorded. The 
following behaviors were rated by the observer:     
 immobility: floating passively in the water without struggling and 
doing only those movements necessary to keep the head above 
water;  
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 swimming: showing moderate active motions around in the 
cylinder, more than necessary to simply keep the head above 
water;  
 climbing: making active vigorous movements with forepaws in 
and out of the water, usually directed against the walls.  
In all the experiments, the observer recorded also the latency to 
immobility, defined as the time at which the rat first adopted an immobile 
posture. 
 
2.2.4 Locomotor activity 
In separate cohorts of rats (48 RHA and 48 RLA), the effects of chronic 
treatments with desipramine, fluoxetine, or chlorimipramine on 
ambulatory activity were assessed in eight photocell activity monitors 
(Opto-Varimex Mini, Columbus, Ohio). After a 5 h period of habituation 
in the test room, animals were placed individually in the center of the 
Perspex cages of the activity meters (50×30×20 cm), and the number of 
interruptions of infrared beams (i.e., counts) were recorded at 5 and 30 
min after the beginning of the test. 
 
2.2.5 Drug administration 
Subacute treatments Two different doses of desipramine (5 and 
20mg/kg), fluoxetine (2.5 and 10mg/kg), chlorimipramine (5 and 
20mg/kg), or vehicle (2 ml/kg) were administered 24, 5, and 1 h prior to 
the start of the test session. Desipramine and fluoxetine were administered 
subcutaneously (s.c.), whereas chlorimipramine was administered 
intraperitoneally (i.p.) in a constant volume (2 ml/kg) of sterile deionized 
water. Drug doses are indicated as milligrams per kilogram of the 
respective salt and were selected on the basis of the previous study by 
Piras et al. [111]. 
 
Chronic treatments Desipramine (5 mg/kg/day), fluoxetine (2.5 mg 
kg/day), chlorimipramine (5 mg/kg/day), or vehicle (2 mg/kg/day) were 
administered i.p. once daily for 15 consecutive days. These doses were 
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selected because they failed to affect the performance of either line in the 
forced swim test upon subacute administration (see left-side panels in 
Figs. 1, 2, and 3; [111]). Forced swim tests and ambulatory activity 
measures were performed 24 h after the last injection of drug or vehicle in 
a counterbalanced order according to drug treatment and animal line. 
 
2.2.6 Data analysis 
Forced swim test The results are expressed as the mean±SEM number of 
behavioral episodes (i.e., immobility, swimming, and climbing) during 
the 5-min swim test and as the mean±SEM latency time (in seconds) to 
the first immobility episode. Separate two-way ANOVAs were performed 
for each behavioral measure, antidepressant drug, and duration of 
treatment (i.e., subacute or chronic), with line (RLA vs. RHA) and 
treatment (i.e., drug dose) as the main factors. Whenever appropriate (i.e., 
P for the main factors and/or their interaction, <0.05), ANOVA was 
followed by pair wise contrasts with the honest significant difference 
Tukey test. 
 
Locomotor activity The results are expressed as the mean±SEM counts/5 
min and counts/30 min. Separate two-way ANOVAs were carried out on 
each drug (main factors: line and treatment with repeated measures over 
time (5 and 30 min)). 
 
 
2.3 Results 
 
2.3.1 Baseline performance of RLA and RHA rats in the 
FST 
 
The behavioral patterns of vehicle-treated RLA and RHA rats shown in 
Figs. 1, 2, and 3 allow a comparison of the baseline performance of the 
two lines in the FST. In line with Piras et al. [111], RLA rats, compared 
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with their RHA counterparts displayed a shorter latency to immobility 
and a higher  immobility frequency (P<0.05), as revealed by two-way 
ANOVAs and post hoc contrasts with the Tukey test. Moreover, the 
frequency of climbing episodes was lower in RLA than in RHA rats 
(P<0.05), whereas no statistically significant line-related differences in 
swimming counts were observed. 
 
2.3.2 Effects of subacute and chronic treatments with 
antidepressants on the performance of RLA and RHA rats 
in the FST 
 
Desipramine 
 
Immobility  Both subacute and chronic treatments with desipramine 
showed significant effects on immobility latency, as indicated by two-
way ANOVA analyses  (subacute: P values<0.01 for line, treatment, and 
their interaction; chronic: P<0.05 for treatment; and P<0.0001 for line x 
treatment) (Fig. 1a). Post hoc contrasts revelead that the effects of 
desipramine were limited to RLA rats. Thus, in this line a significant 
increase in immobility latency was observed upon either the subacute 
desipramine administration of 20 mg/kg, or the repeated one at the dose 
of 5 mg/kg/day. Significant changes were observed also in the frequency 
of immobility episodes (subacute: effects of line, treatment and 
interaction with P values<0.0001; chronic:  P<0.01 for treatment and 
interaction); in particular, post hoc analyses revealed that immobility 
frequency was decreased in RLA but not RHA rats after subacute 
treatment only at the high dose (20mg/kg), while the low dose (5 mg/kg) 
was sufficient to induce a similar reduction in the frequency of 
immobility of RLA rats when administered chronically. (Fig. 1b). 
Swimming No significant effects on swimming counts were detected with 
either subacute or chronic desipramine treatments (P values for the effects 
of line, treatment, and their interaction, >0.05) (Fig. 1c). 
 
Climbing Climbing scores were significantly affected by both, subacute 
and chronic desipramine treatments (subacute: P values for the effect of 
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line, treatment and their interaction, <0.02; chronic: significant effect of 
line, P<0.05; and treatment, P<0.01). In RLA but not RHA rats, post hoc 
comparisons revealed a significant increment in  climbing frequency upon 
subacute treatment with 20 mg/kg of desipramine,  and upon the repeated 
administration of desipramine at the dose of 5 mg/kg/day (Fig. 1d). 
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Fig. 1 Effects of desipramine on the behavioral performance of RLA and RHA rats 
in the FST. Columns and bars indicate the mean ± SEM number of counts of 3 rats per 
group. Left-hand panels show the effects of the subacute administration of  2ml/kg of 
vehicle (desipramine = 0), or desipramine (5mg/kg and 20 mg/kg) on immobility latency 
(a), immobility frequency (b), swimming frequency (c), and climbing frequency (d). 
Right-hand panels show the effects of the repeated daily administration of vehicle or 
desipramine (5mg/kg) for 15 consecutive days on the behavioral measures described 
above. *: P<0.05 vs the treatment-matched RLA line. §: P<0.05 vs the line-matched 
vehicle-treated controls. 
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Fluoxetine 
 
Immobility Two-way ANOVA analyses revealed significant effects of  
line and line x treatment interaction on immobility latency upon subacute 
and chronic fluoxetine treatments (Fig. 2a) (both subacute and chronic: 
P<0.01 for line and P≤0.05 for line x treatment interaction). A tendency 
towards an increase in immobility latency was observed in RLA but not 
RHA rats upon the subacute treatment at the dose of 10 mg/k and the 
chronic administration of 2.5 mg/kg/day (P<0.16 and P=0.12, 
respectively). Subacute and chronic fluoxetine treatments significantly 
changed immobility frequency (subacute: P<0.01 for all the main factors; 
chronic: P<0.01 for line, P=0.05 for treatment and P<0.001 for their 
interaction). As shown by post hoc contrasts, immobility scores were 
decreased in RLA but not RHA rats either after subacute treatment at the 
high dose of 10 mg/kg or  after the repeated administration of fluoxetine 
at the dose of 2.5 mg/kg/day (P<0.001 and P<0.05 versus the vehicle-
treated controls of the same line for subacute and chronic treatments, 
respectively) (Fig. 2b). 
Swimming As shown in Fig. 2c, the number of swimming episodes was 
significantly modified after subacute and chronic treatments with 
fluoxetine (ANOVA analysis revealed all P values <0.001 for the 
subacute treatment and all P values <0.0001 for the chronic treatment). 
Post hoc analysis revealed that the subacute treatment at the dose of 10 
mg/kg significantly increased swimming frequency (P<0.001) in RLA but 
not RHA rats, whereas the chronic treatment at the dose of 2.5 mg/kg/day 
induced a similar increment only in RLA rats (P<0.001).   
 
Climbing In both lines, climbing counts were not modified by either  
subacute or chronic treatments with fluoxetine (Fig. 2d). However, RHA 
rats displayed an overal higher frequency of climbing episodes compared 
with their RLA counterparts: ANOVA analyses indicated a significant 
effect of line for both subacute (P<0.0001) and chronic treatments 
(P<0.01). 
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Fig. 2 Effects of fluoxetine  on the behavioral performance of RLA and RHA rats in 
the FST. Columns and bars denote the mean ± SEM number of counts of 3 (subacute) or 
7 (chronic) rats per group. Left-hand panels show the effects of the subacute 
administration of  2ml/kg of vehicle (fluoxetine = 0), or fluoxetine (2.5mg/kg and 10 
mg/kg) on immobility latency (a), immobility frequency (b), swimming frequency (c), 
and climbing frequency (d). Right-hand panels show the effects of the repeated daily 
administration of vehicle or fluoxetine (2.5mg/kg) for 15 consecutive days on the 
behavioral measures described above. *: P<0.05 vs the treatment-matched RLA line. §: 
P<0.05 vs the line-matched vehicle-treated control group. 
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Chlorimipramine 
 
Immobility As indicated by ANOVA analyses, the latency to the first 
immobility episode was significantly affected by both, the subacute (all P 
values <0.025) and the chronic treatments (significant effect of line x 
treatment interaction: P<0.025) with chlorimipramine (Fig. 3a). 
Subsequent pair wise contrasts showed that after subacute treatment only 
the high dose (20 mg/kg) induced an increment in immobility latency in 
RLA (P<0.01) but not RHA rats, whereas the low dose of 
chlorimipramine (5 mg/kg) given repeatedly for 15 days significantly 
increased the latency time in RLA rats as compared with their respective 
vehicle-treated controls (P<0.025). Similarly, chlorimipramine induced 
significant changes on immobility frequency upon both subacute (all P 
values <0.001) and chronic treatment (P=0.01 for treatment and P<0.001 
for line x treatment interaction). In addition, in RLA but not in their RHA 
counterparts, post hoc contrasts revealed a significant reduction in 
immobility frequency following the subacute treatment at the high dose of 
20 mg/kg (P<0.001 versus vehicle-treated RLA rats), and the repeated 
administration of chlorimipramine at the dose of 5 mg/kg/day (P<0.001 
versus RLA vehicle-treated) (Fig. 3b). 
 
Swimming ANOVA analyses indicated that both subacute and chronic 
chlorimipramine treatments failed to induce significant changes in the 
frequency of swimming episodes in either line (P values for the effects of 
line, treatment, and their interaction, >0.05) (Fig. 3c). 
 
Climbing Significant effects on climbing scores were reported after 
subacute (all P values <0.025) and chronic treatments with 
chlorimipramine (P<0.025 for the effect of line and P<0.05 for the line x 
treatment interaction) (Fig. 3d). Post hoc contrasts revealed that the 
subacute treatment increased climbing frequency only in RLA rats 
(P<0.005) at the dose of 20 mg/kg; on the other hand, only a tendency 
towards an increase in the climbing scores was observed in RLA rats 
(P=0.10) but not in their RHA counterparts after the repeated 
administration of chlorimipramine at the dose of 5 mg/kg/day. 
 
42 
 
 
0
100
200
300
400
500
.
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
§
*
*
IM
M
O
B
IL
IT
Y
L
A
T
E
N
C
Y
 (
s
)
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
*
§
0
10
20
30
40
.
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
* *§IM
M
O
B
IL
IT
Y
C
O
U
N
T
S
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
*§
0
10
20
30
40
.
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
S
W
IM
M
IN
G
C
O
U
N
T
S
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
0
10
20
30
40
50
60
70
.
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
* *
§
C
L
IM
B
IN
G
C
O
U
N
T
S
.
.
RLA
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
RHA
*
a
b
c
d
SUBACUTE CHRONIC
0 5 20 0 5 20 0 5 0 5
CHLORIMIPRAMINE
 
Fig. 3 Effects of chlorimipramine on the behavioral performance of RLA and RHA 
rats in the FST. Columns and bars indicate the mean ± SEM number of counts of 3 
(subacute) or 5 (chronic) rats per group. Left-hand panels show the effects of the 
subacute administration of  2ml/kg of vehicle (chlorimipramine = 0), or chlorimipramine 
(5mg/kg and 20 mg/kg) on immobility latency (a), immobility frequency (b), swimming 
frequency (c), and climbing frequency (d). Right-hand panels show the effects of the 
repeated daily administration of vehicle or chlorimipramine (5mg/kg) for 15 consecutive 
days on the behavioral measures described above. *: P<0.05 vs the treatment-matched 
RLA line. §: P<0.05 vs the line-matched vehicle-treated control group. 
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Collectively, these results show that chronic treatments with desipramine, 
fluoxetine, and chlorimipramine reduced immobility and increased active 
behaviors in RLA but not RHA rats, at doses that were ineffective when 
administered subacutely. 
 
To exclude potential false positive effects, due to the potentiation of 
monoaminergic transmission [173, 174, 179] induced by these 
antidepressant drugs, locomotor activity was measured following  the 
same chronic treatment regimens used in the FST. 
 
2.3.3 Locomotor activity 
The effects of chronic treatments with desipramine, fluoxetine and 
chlorimipramine on the locomotor activity of RLA and RHA rats are 
indicated in Table 1. For each drug, two-way ANOVA analyses (main 
factors, line (RLA vs. RHA) and treatment (saline vs. antidepressant) with 
repeated measures over time (5 and 30 min)) revealed no significant 
effects of chronic treatments on the locomotor activity of either line. 
Notably, the same doses that failed to affect locomotor activity were able 
to produce reliable behavioral effects in the FST performance of RLA 
rats. This finding demonstrates that non specific motor effects are not 
involved in the reduction of immobility and increase in active behaviors 
observed in RLA rats upon the chronic administration of desipramine, 
fluoxetine or chlorimipramine. 
 
On the other hand, it is interesting to note that a tendentially higher 
number of ambulatory counts was observed in control RHA rats (i.e., 
chronically treated with saline) as compared with their RLA counterparts. 
This result is in line with several previous reports indicating that RHA 
rats display a more intense locomotor activity than RLA rats when 
exposed to a novel environment [86, 88, 180, 181]. 
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Fig. 4 Effects of chronic treatments with desipramine, fluoxetine and 
chlorimipramine on the locomotor activity of RLA and RHA rats. Columns and bars 
indicate the mean ± SEM number of cumulative counts of 8 rats per group recorded at 5 
and 30 min after the start of the test.  RLA and RHA rats were injected i.p. for 15 
consecutive days with either vehicle (2 ml/kg/day: drug = 0) or drug at the following 
doses: desipramine, 5 mg/kg/day ; fluoxetine, 2.5 mg/kg/day; chlorimipramine, 5 
mg/kg/day, and ambulatory activity was measured 24 h after the last injection of the 
drug or vehicle. 
 
 
2.4 Discussion 
 
This study confirms the differences between the performance of the 
Roman lines in the FST under baseline conditions, with RLA rats 
showing greater immobility and fewer active behaviors than RHA rats 
and demonstrates that such results are replicable even with a single 
exposure to the swim test (i.e., the swim test not preceded by the 
induction pretest). In this context, it is important to keep in mind that the 
usual paradigm of FST consists of a 5-min swim test preceded, 24 h 
before, by a pre swim session in which the animal is exposed for the first 
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time to inescapable swim for 15 min. The pretest serves as an induction 
procedure that facilitates passive behaviors on subsequent swim exposure 
thereby allowing a clearer observation of the effects of antidepressants on 
the performance in the FST. However, the decrease in the latency to 
immobility elicited on the subsequent test may be interpreted as a 
"learned immobility" rather than a "behavioral despair". The results 
obtained in the Roman rats with a single exposure to the FST suggest that 
the passive strategy displayed by RLA rats in the FST denotes an innate 
trait, rather than the consequence of a previous exposure to stress. 
Moreover, this study shows that low doses of desipramine (5 mg/kg), 
fluoxetine (2.5 mg/kg) and chlorimipramine (5 mg/kg),which were not 
effective when given subacutely, became fully effective upon chronic 
treatment in RLA rats but not in their RHA counterparts.  
The pattern of active behaviors displayed by RLA rats chronically treated 
with low doses of desipramine and fluoxetine was similar to that observed 
after subacute treatments with higher doses of the same drugs. Thus, in 
line with several reports on the effects of selective norepinephrine 
reuptake inhibitors (SNRI) in the FST, desipramine increased climbing 
behaviors in RLA rats. On the other hand, fluoxetine increased swimming 
in RLA rats, as reported in studies using selective serotonin reuptake 
inhibitors (SSRIs) other than fluoxetine. Notably,  clinical studies show 
that selective inhibitors of either NE or 5-HT reuptake induce initial 
improvements in different symptoms of depression. In particular, SNRIs 
initially improve motor retardation and depressed mood, while the early 
effects of SSRIs include a reduction in anxiety followed by improvement 
in depressed mood and cognitive function [182]. 
Interestingly, chlorimipramine, which is a nonspecific dual NE/5-HT 
reuptake inhibitor, presented a mixed profile: subacute high doses 
increased climbing scores, whereas the chronic administration of low 
doses had no significant effect on climbing behavior, but increased 
swimming when the behaviors were recorded for a longer period (i.e., 15 
min instead of 5 min, results not shown). 
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Thus, in keeping with previous reports, the present study shows that 
antidepressants with different mechanisms of action differentially affect 
climbing and swimming in the FST (for a review see [178]). Moreover, 
the different behavioral effects induced by antidepressants with distinct 
molecular targets may be selectively associated with the specific 
therapeutic efficacy of each drug on different symptoms of depression. 
This finding confers a potential predictive value to such behavioral 
patterns that may be exploited for designing novel and more efficient 
antidepressant drugs [182].   
Furthermore, it is noteworthy that the efficacy of chronic antidepressant 
treatments on RLA rats, as well as the lack of antidepressant effects on 
RHA rats, are consistent with two important lines of clinical evidence: (i) 
the delay (at least two weeks) necessary to have the first therapeutic 
effects following antidepressant treatments, and (ii) the lack of major 
effects on mood in normal (i.e., non depressed) subjects [183, 184].  
Therefore, the present study adds experimental support to the hypothesis 
that RLA and RHA rats may represent a valid preclinical model of, 
respectively, vulnerability and resistance to stress-induced depression. 
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3. Study II: Involvement of dopamine in 
the different patterns of sexual behavior 
of Roman high and low avoidance rats: 
behavioral characterization, 
pharmacological assays and intracerebral 
microdialysis study. 
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3.1 Introduction 
 
RLA and RHA rats display different coping styles and behavioral profiles 
in experimental paradigms used to assess emotionality/fearfulness, as well 
as in tests used to evaluate the responsiveness to natural or drug rewards,. 
These differences may be due, at least in part, to distinct line-related 
functional properties of brain dopaminergic transmission [87, 115, 185-
187], although serotonin and other neurotransmitters cannot be ruled out 
[187-190]. In line with the above studies, differential dose-related 
responses between the inbred RLA and RHA rat strains in terms of 
motility, stereotypy, and yawning induced by the D1/D2 mixed dopamine 
(DA) receptor agonist apomorphine have been observed [191]. Moreover, 
the pro-yawning and pro-erectile effects of apomorphine and the pro-
erectile effect of PD 168,077, a selective D4 receptor agonist, are more 
pronounced in outbred RLA rats than in their RHA counterparts and in 
Sprague Dawley (SD) rats [192]. It is noteworthy in this context that 
dopamine facilitates both the anticipatory (i.e., motivational and 
rewarding) and the consummatory (i.e., penile erection and copulatory 
performance) aspects of sexual behavior in experimental animals and in 
humans, by acting in the medial pre-optic area and hypothalamic nuclei 
[156-163]and in mesolimbic brain areas (i.e., ventral tegmental area and 
nucleus accumbens) [164, 165, 167-169]. 
 
On the bases of the above premises, we hypothesized that RHA and RLA 
rats might show a different behavioral profile also when tested in a 
classical experimental paradigm aimed at characterizing copulatory 
behavior with a receptive (ovariectomized and oestrogen–progesterone-
primed) female rat.  
 
In order to verify this hypothesis, we performed: 
a) an extensive characterization of sexual behavior of male RHA and 
RLA rats exposed to a sexually receptive female rat in a series of classic 
copulatory tests; 
b) pharmacological assays with the DA agonist apomorphine and DA 
antagonist haloperidol, given alone or in combination, to evaluate the 
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differential effects of DA transmission on the copulatory performance of 
RHA and RLA rats; 
c) intracerebral microdyalisis in the nucleus accumbens shell (AcbSh) 
during sexual behavior of sexually naïve and sexually experienced RHA 
and RLA rats to evaluate the release of DA in this brain area that is 
critically involved in the anticipatory and consummatory phases of sexual 
behavior. 
 
 
3.2 Materials and methods 
 
3.2.1 Animals 
Outbred Roman high- (RHA) and low-avoidance (RLA) male rats (350–
375 g at the beginning of the experiments) were from the colony 
established in 1998 at the University of Cagliari, Italy. Ovariectomized 
Sprague Dowley (SD) female rats (250–330 g at the beginning of the 
experiments) were obtained from Charles River (Como, Italy) for the 
behavioral and pharmacological assays, whereas for the microdialysis 
study they were obtained from Harlan Nossan (Correzzana, Italy). 
Animals were housed 4 per cage (38 cm × 60 cm × 20 cm) and were 
acclimated to the housing facilities of the Department of Biomedical 
Sciences of the University of Cagliari for at least 10 days before the 
beginning of the experiments under controlled environmental conditions 
(24 °C, 60% humidity, reversed 12 h light/dark cycle with lights off from 
08:00 to 20:00 h) and with free access to water and standard laboratory 
food. To limit the stress due to manipulation during the experiments, each 
animal was daily handled for approximately 1-2 min; in addition, contact 
with the  animal house maintenance personnel was limited to a single 
attendant, and bedding in the home cages was not changed in the two 
days preceding the test. All the procedures were performed in accordance 
with the guidelines and protocols approved by the European Union (EU 
Council 86/609; D.L. 27.01. 1992, no.116) and by the Ethical Committee 
for Animal Care and Use of the University of Cagliari. 
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3.2.2 Experimental groups 
(a) Behavioral characterization: 15 male rats from each line were used 
(15 SD male rats were also used as a reference strain, but the results are 
not presented in this section, for the detailed study see [193]). All the 
animals, never exposed to a sexually receptive female, underwent five 
consecutive 60 min copulation tests at 3-day intervals. 
 
(b) Pharmacolgical assays: 45 male rats from each line were used (45 SD 
male rats were also used as a reference strain, but the results are not 
presented in this section, for the detailed study see [194]). All the animals, 
never exposed to a sexually receptive female, underwent five consecutive 
45 min copulation tests at 3-day intervals. 
Five days after these preliminary copulation tests, sexually experienced 
male rats that satisfied the criterion of at least one ejaculation reached in 
each of the last two tests were randomly divided into three groups of 12 
animals for each line/strain, the first group was used to study the effect of 
apomorphine, the second the effect of haloperidol and the third the effect 
of haloperidol + apomorphine on copulatory behavior. 
(c) Intracerebral microdialysis study: 12 animals for each experimental 
group were used. The groups were divided into sexually naïve and 
sexually experienced for each line. Sexually naïve rats were adult male 
RHA and RLA rats never exposed to a sexually receptive female, whereas 
sexually experienced rats were previously exposed to five consecutive 
classical copulation tests at three-day intervals. Two days after these tests, 
sexually experienced male rats that satisfied the criterion of at least one 
ejaculation reached in each of the last two tests, and all the sexually naïve 
animals, were included in the microdialysis studies.  
  
3.2.3 Copulatory behavior (studies a, b, c) 
Briefly, male rats from each line/strain were moved during the dark phase 
of the cycle to a room lit by a dim red light where they were housed 
individually in a mating cage (45 cm × 30 cm × 24 cm) for 120 min. At 
the end of this habituation period a stimulus female rat (different for each 
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test) was introduced in the male's home cage. Estrous was induced in 
ovariectomized female rats by subcutaneous injections of estradiol 
benzoate (200 μg/rat in 0.2 ml of peanut oil) and progesterone (0.5 mg/rat 
in 0.2 ml of peanut oil) 48 and 6 h before the behavioral tests, 
respectively. In each test, the following measures of copulatory behavior 
were recorded:  
 mount and intromission latency (ML and IL, the time elapsed 
since the introduction of the female into the experimental cage 
until the first mount and/or the first intromission, respectively); 
 mount and intromission frequency (MF and IF, the number of 
mounts and intromissions in a series of copulatory activity 
(henceforth named series, with the first series beginning with the 
first mount/intromission and ending with the first 
mount/intromission after the first ejaculation, the second one 
beginning with the first mount/intromission after the first 
ejaculation and ending with the first mount/intromission after the 
second ejaculation, and so on), respectively; 
 ejaculation latency (EL, timed from the first intromission until 
ejaculation in a series); 
 ejaculation frequency (EF, the number of ejaculations in the 60 
min of testing); 
  post-ejaculatory interval (PEI, the time from ejaculation until the 
next intromission).  
 
In addition, the following parameters were calculated: (1) copulatory 
efficacy (CE, number of intromissions recorded during a given series 
divided by the sum of mounts and intromissions in the same series) and 
(2) the inter-intromission interval (III, the ratio between the EL of a given 
series and the number of intromissions in that series) (see [195] and 
references therein). Unless otherwise stated, these parameters refer to the 
first series.  
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3.2.4 Drug administration (study b) 
Apomorphine was dissolved in saline and administered subcutaneously 
(SC) in a volume of 0.2 ml/200g body weight, 10 min before the 
introduction of the receptive female in the mating cage. Haloperidol was 
dissolved with a drop of acetic acid diluted with distilled water at a 
pH=5.0 and administered intraperitoneally (IP) in a volume of 1ml/ 200g 
of body weight, 30 min before the introduction of the receptive female in 
the mating cage. When haloperidol was given in combination with 
apomorphine, the drug was administered 20 min before apomorphine. 
Controls received the same volume(s) of the appropriate vehicle(s). 
 
3.2.5 Intracerebral microdialysis in the AcbSh during 
sexual behavior (study c) 
The day before the microdialysis experiment, naïve or sexually 
experienced RHA and RLA rats were stereotaxically implanted (Stoelting 
Co., Wood Dale, IL, USA), under isoflurane anaesthesia (1.5–2%) 
(Harvard Apparatus, Holliston, MA, USA), with a microdialysis probe 
with a U-shaped dialysis membrane (approximately 2 mm of free surface 
for dialysis), prepared as previously described [162], and aimed 
unilaterally at the AcbSh (coordinates: 1.8 mm anterior and 0.8 mm 
lateral to bregma, and 7.8 mm ventral to dura) [196]. The day of the 
experiment, during the dark phase of the cycle, the rats were transferred to 
a mating cage (45 cm × 30 cm × 24 cm) which contained another small 
Plexiglas cage (15 cm × 15 cm × 15 cm) with 25 holes (Ø 2 mm) in each 
vertical wall to allow for visual, olfactory and acoustic interaction. After a 
2 h habituation period, the microdialysis probe was connected via 
polyethylene tubing to a CMA/100 microinfusion pump (Harvard 
Apparatus, Holliston, MA, USA) and perfused with Ringer’s solution, 
containing 147 mM NaCl, 3 mM KCl and 1.2 mM CaCl2, pH 6.5, at a 
constant flow rate of 2.5 μL/min. After a 2 h equilibration period, 
dialysates were collected throughout the experiment every 15 min in 
aliquots of 37.5 μL for the determination of dopamine concentrations, as 
described in Fig.1.  
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Collection of dialysates every 15 min in aliquots of 37,5 μL
1) Habituation period (2h);
 collection of 4 dialysate aliquots to determine the basal
concentration of dopamine in the AcbSh;
2) Introduction of the female (inacessible): in these
conditions male rats that can see, hear and smell but not
touch the female, show non contact erections (30 min);
 collection of 2 dialysate aliquots to determine the
concentrations of dopamine in the AcbSh during the
anticipatory phase, which reflects the motivational aspects
of sexual behavior;
3) Sexual interaction and Copulation (75 min);
 collection of 5 dialysate aliquots to determine dopamine
concentrations in the AcbSh during the consummatory
phase, which reflects the motivational and performing
aspects of sexual behavior.
4) Female removal (15 min)
An additonal dialysate aliquot was collected after removing
the female from the mating cage.
  
Fig.1 Intracerebral microdialysis during sexual behavior 
 
All behavioral parameters of sexual activity were recorded throughout the 
experiment. In addition, non contact erections (pheromone-mediated 
penile erections that male rats show in the presence of an inaccessible 
sexually receptive female) were recorded. 
Dopamine concentrations in 20 μL of dialysates were measured by high 
pressure liquid cromatography (HPLC) coupled to eletrochemical 
detection (for details see [197] .  
 
3.2.6 Data analysis 
(a) Behavioral characterization Line related differences in the frequency 
of mounts, intromissions  and ejaculations along copulation tests 1 to 5 
were evaluated with the chi-square (χ2) test (not shown here). Differences 
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in behavioral patterns between lines during the first sexual experience 
(first series of the first copulation test) of naïve male rats were assessed 
by one-way ANOVA. An overall assessment of sexual behavior during 
the first series across tests 1 to 5 was performed by using the trapezoidal 
rule to calculate the AUCs in plots of each behavioral measure vs. test 
number for every rat. The average AUCs for each line/strain were 
compared by using one-way ANOVA. The comparison between the first 
series of copulation tests 1 to 5 was performed by repeated measures 
ANOVA.  
 
(b) Pharmacolgical assays  Differences between lines in the copulatory 
parameters of the first series of copulatory activity after treatment were 
analyzed for each treatment group (i.e., apomorphine, haloperidol and 
haloperidol + apomorphine) by two-way ANOVA with repeated measures 
over treatment (main effects: "line" and "treatment"). Differences in the 
control values of copulatory parameters in the first series of copulatory 
activity recorded from RLA and RHA rats treated with vehicle(s) (drug 
dose = 0) were analyzed by two-way ANOVA (between subjects factors: 
"control condition" and "line"). 
 
(c) Intracerebral microdialysis study Statistical analyses of biochemical 
(dopamine concentration in the AcbSh) and behavioral (non contact 
erections, ML, IL and EL and MF, IF and EF) data were conducted in 
each experimental subject. An overall analysis of the data obtained from 
each rat during the microdialysis experiments was first performed by 
calculating the AUCs of the plots of dopamine concentrations and the 
number of non contact erections, mounts, intromissions and ejaculations 
versus time and then comparing the obtained values by two-way ANOVA 
with the rat line and the sexual experience as between subjects factors. A 
more detailed analysis of each set of biochemical and behavioral data was 
then conducted by two way ANOVAs with the rat line or the sexual 
experience as between subject factors and time as within subject factor. 
An additional analysis was conducted on the values of the behavioral 
parameters obtained in the first series of copulatory activity (i.e., from the 
first mount/intromission to the first mount/intromission after the first 
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ejaculation) of naïve and sexually experienced male RHA and RLA rats 
during the microdialysis experiments. In this case, two way ANOVAs 
with the rat line and the sexual experience as between subjects factors 
were conducted on the following parameters: ML, IL, EL, MF, IF, EF, 
PEI, III and CE. 
In all the studies when ANOVAs revealed statistically significant main 
effects and/or interactions, post hoc pair wise contrasts were performed 
with the Bonferroni's test. 
    
 
 
    
 
Fig. 2 Schematic representation of a coronal section of the rat brain showing the 
track of the microdialysis probe in the AcbSh. Insert: the square bracket in the 
microphotograph indicates the active portion of the dialyzing membrane. Abbreviations: 
ac=anterior commissure; Cpu = caudate-putamen; AcbSh = nucleus accumbens shell; 
AcbC = nucleus accumbens core. 
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3.3 Results 
 
3.3.1 Behavioral characterization (a) 
Percentage of rats engaged in sexual activity  Male RHA rats engaged in 
sexual behavior with a receptive female much better than RLA rats since 
the first test, in which more than 80% of RHA rats showed mounts and 
intromissions and reached ejaculation in the first series as compared with 
only 40-50% of RLA rats. Although less marked, such differences 
between RHA and RLA rats were still present in the second and third 
copulation tests but were no longer statistically significant in the fourth 
and fifth tests. Additionally, while almost 100%  of RHA rats reached 
ejaculation in the first series already in the second test, RLA rats 
improved their performance along the tests but did not achieve the levels 
of RHA rats, reaching a maximum of ~80% in the last two tests (results 
not shown here, see Sanna et al., 2014a). 
 
Sexual behavior in naïve male rats One-way ANOVA analysis of the 
copulatory parameters measured in the first series of test 1, shows 
significant differences in the pattern of copulatory activity between the 
two Roman lines (Fig. 3). Thus, post hoc contrasts revealed significantly 
shorter ML and IL (both P<0.05) and higher MF (p<0.05) and IF 
(p<0.001) in RHA rats compared with their RLA counterparts. 
Conversely, no difference was found in the EL of the two lines. 
Considering that intromissions are preliminaries to reach ejaculation, the 
lack of differences in the EL combined with the higher IF shown by RHA 
rats explain why the III was longer in RHA vs RLA rats (P<0.001). 
Another important difference was the shorter PEI displayed by RHA 
compared with RLA rats (P<0.05). 
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Fig. 3 Sexual behavior of male RHA and RLA rats in the first series of the 
copulation test 1**  Columns and bars indicate the means ± SEM of 15 rats per line. a: 
P<0.05 vs RLA (one-way ANOVA followed by Bonferroni's post hoc contrast). Animals 
that did not mount/intromit/ejaculate within a given time were assigned full range values 
for latencies (900 s if the animal did not mount or intromit within 15 min after the 
presentation of the female; 1800 s if the animal did not reach ejaculation within 30 min 
from the first intromission and 600 s if the male did not intromit within 10 min after the 
last ejaculation). ** except for ejaculation frequency that is calculated as the number of 
ejaculations recorded in the entire test 1. 
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Differential effects of sexual experience  Assessment of the first series of 
each copulatory test indicates that the behavioral patterns of RHA and 
RLA rats changes differentially across tests 1 to 5. Thus, compared with 
test 1, such changes were more robust in test 2, some still occurred in test 
3, and very minor or no changes were found in tests 4 and 5, suggesting 
that a stable copulatory pattern was reached after three consecutive tests: 
in both RHA and RLA rats there was a tendency towards a reduction of 
the latencies (ML, IL and EL) and the frequency of mounts (that can be 
considered as failed intromissions), whereas EF increased, PEI and III 
decreased, and IF remained unchanged, leading to an increment of the 
CE. Despite the above mentioned common trend, one-way ANOVA 
analysis of the AUCs of the curves shown in Fig. 4 revealed significant 
line-related differences for the first series of copulatory parameters along 
the five tests. These results were further confirmed by two-way ANOVA 
for repeated measures. Moreover, post hoc contrasts showed that the ML 
of RLA rats was persistently longer than that of RHA rats in all five 
copulation tests (P<0.05). Notably, ML is the only parameter in this study 
that can be considered as an index of sexual motivation (i.e., the longer 
the ML, the lower the motivation). 
 
In summary, male RHA rats displayed a more robust sexual motivation 
and a better copulatory performance than RLA rats, in keeping with their 
different behavioral profile and proactive coping style. These differences 
were more pronounced during the first exposure to a sexually receptive 
female but persisted, albeit attenuated, after repeated copulation tests.  
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Fig. 4 Sexual behavior of male RHA and RLA rats in the first series of copulation 
test 1, 2, 3, 4, 5** . Shown are the means±SEM of 15 rats per line. a: P<0.05 vs RLA; *: 
P <0.05 vs the within line value in copulation test 1 (two-way ANOVA for repeated 
measures followed by Bonferroni's post hoc contrasts). ** except for ejaculation 
frequency that is calculated as the number of ejaculations recorded in each entire 
copulation test. 
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3.3.2 (b) Pharmacological assays (apomorphine and 
haloperidol) 
Effects of apomorphine on copulatory behavior of sexually experienced 
RLA and RHA rats   Fig. 5 shows that apomorphine (0.02 and 0.08 
mg/kg s.c.) facilitated copulatory behavior of both RLA and RHA rats in 
a dose-dependent manner, as indicated by the decrease of the EL and the 
increase of the EF, as compared with the respective vehicle-treated 
groups. Importantly, the threshold apomorphine dose was four-fold higher 
for RHA rats (0.08 mg/kg) than RLA rats (0.02 mg/kg). 
Effects of haloperidol on copulatory behavior of sexually experienced 
RLA and RHA rats  As shown in Fig. 6, haloperidol (0.1 and 0.2 mg/kg 
i.p.) had only minor effects on sexually experienced RHA rats, but 
impaired copulatory behavior of sexually experienced RLA rats. Thus, in 
RLA rats, the dose of 0.2 mg/kg significantly increased ML, IL, EL, III 
and PEI values compared with the respective vehicle-treated group (all P 
values<0.05). Conversely, no change was observed in the copulatory 
parameters of RHA rats treated with either 0.1 mg/kg or 0.2 mg/kg, 
except for the IF and CE values, which decreased in a dose-dependent 
manner compared to the control condition (haloperidol = 0), as observed 
also in RLA rats. 
Effects of haloperidol + apomorphine on copulatory behavior of 
sexually experienced RLA and RHA rats  As shown in Fig. 7, 
haloperidol (0.1 and 0.2 mg/kg IP) given 20 min before apomorphine 
(0.08 mg/kg SC), differentially antagonized in a dose-dependent manner 
the facilitatory effect of apomorphine on copulatory behavior in sexually 
experienced rats of both lines. The effect of haloperidol was particularly 
evident in RLA rats, in which it abolished all the changes induced by 
apomorphine already at the dose of 0.1 mg/kg, and, at the dose of 0.2 
mg/kg, it induced changes that were similar to those observed when it was 
given alone. In contrast, in apomorphine-treated RHA rats, the effect of 
haloperidol was very small, albeit significant, (increased MF, decreased 
CE and longer PEI compared to vehicle + apomorphine-treated rats).  
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Fig. 5 Effects of apomorphine on copulatory behavior of sexually experienced RHA 
and RLA rats  Shown are the means ± SEM of 12 rats per group. a: P<0.05 vs RLA; *: 
P<0.05 vs the respective vehicle treated-group (apomorphine = 0) 
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Fig. 6 Effects of haloperidol on copulatory behavior of sexually experienced RHA 
and RLA rats Shown are the means ± SEM of 12 rats per group. a: P<0.05 vs RLA; *: 
P<0.05 vs the corresponding group treated with vehicle alone (haloperidol = 0). 
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Fig. 7 Effects of haloperidol on apomorphine-induced changes in copulatory 
behavior of sexually experienced RHA and RLA rats Columns and bars indicate the 
means ± SEM of 12 rats per group. V: vehicle V+S: vehicle + saline; A: Apomorphine 
(0.08 mg/kg, s.c.); H1: haloperidol 0.1 mg/kg, i.p.; H2: haloperidol 0.2 mg/kg, i.p. 
Haloperidol (H1 or H2) or vehicle alone (V) were given 20 min before apomorphine. a: 
P<0.05 vs RLA; *: P<0.05 vs the line-matched vehicle-treated (V+S) group; #: P<0.05 
(H1+A) or (H2+A) vs (V+A). 
 
 
Both apomorphine and haloperidol were more effective in sexually 
experienced RLA than RHA rats, suggesting a greater responsiveness of 
RLA rats to both the stimulation and the blockade of dopamine receptors. 
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3.3.3  Intracerebral microdialysis studies (c) 
Dopamine concentrations in the AcbSh of sexually naïve RHA and RLA 
rats  (Fig. 8 upper panel) Two main findings emerged from the brain 
microdialysis experiments in sexually naïve Roman rats. Firstly, the basal 
concentrations of extracellular DA of RHA and RLA rats were 
statistically indistinguishable. Secondly, the overall DA content during the 
anticipatory and consummatory phases of sexual activity was 
significantly higher in naïve RHA than RLA rats (P<0.001 and P<0.05, 
respectively). Interestingly, in RHA rats, the extracellular DA 
concentrations already started to increase upon the introduction of the 
inaccessible female (47.5% above basal values, P<0.01 in the second 15 
min fraction), whereas in RLA rats the first significant increase in 
extracellular DA concentrations (51.3% above the basal values) occurred 
only during copulation. These results are consistent with a more robust 
motivation of RHA rats compared with their RLA counterparts. 
Dopamine concentrations in the AcbSh of sexually experienced RHA 
and RLA rats (Fig. 8 bottom panel)  Increases in extracellular DA also 
occurred in sexually experienced RHA and RLA rats with significant 
line-related differences in the time course. Notably, the basal DA 
concentrations were statistically indistinguishable both across animal line 
and sexual experience, suggesting that sexual experience per se does not 
alter the basal dopamine output in the AcbSh. Most important, in sexually 
experienced RLA rats, the overall dopamine content was significantly 
larger during copulation than in their naïve counterparts (P<0.05), 
whereas no such difference was observed between sexually experienced 
and naïve RHA rats. In RHA rats, however, sexual experience is 
associated with an earlier increment in DA output upon the introduction 
of the inaccessible female as compared with the sexually naïve group 
(57.2% after the first 15 min), and also an anticipation of the increase in 
DA output during copulation, as reflected by the peak value at 30 min of 
copulation (147.4% above basal values, compared with 184.2% recorded 
after 60 min of copulation in the sexually naïve RHA group). 
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Fig. 8 Dopamine concentrations in the AcbSh dialysates from sexually naïve (upper 
panel) and sexually experienced (bottom panel) RHA and RLA rats during sexual 
activity Shown are the means ± SEM of 12 (naïve) or 10 (experienced) rats per group. *: 
P<0.05 vs the basal values of the same line; a: P<0.05 vs the corresponding value of the 
RLA group; b: P<0.05 vs the time-matched value of the line-matched sexually naïve 
group. IF: inacessible female; C: copulation; FR: female removal. 
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Effect of sexual experience on the copulatory patterns of RHA and RLA 
rats  (Fig. 9) The differences observed in dopamine output in both 
sexually naïve and experienced rats occurred concomitantly with changes 
in several sexual parameters recorded during the two main phases of the 
experiment: female inaccessible and copulation. Thus, statiscal analysis 
revealed that both sexually naïve and experienced RHA rats displayed 
more frequent non contact erections, mounts, intromissions and 
ejaculations than their respective naïve and experienced RLA rats. In 
keeping with the results regarding the accumbal dopamine output of RHA 
rats, sexual experience caused changes in the time course rather than in 
the frequency of the recorded behavioral measures. On the other hand, in 
RLA rats, sexual experience led to a general improvement of the 
performing aspects and, less markedly, of the appetitive aspects of sexual 
activity. 
Thus, RHA and RLA rats, either when exposed to an inaccessible female 
or during copulation, show different patterns of sexual activity associated 
with differential changes in the concentrations of extracellular dopamine 
in the AcbSh. Although more pronounced in sexually naïve rats, the 
differences in mesolimbic dopamine release persist after acquisition of a 
stable baseline of sexual activity. 
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Fig. 9 Behavioral patterns of sexually naïve (upper panel) and sexually experienced  
(bottom panel) RHA (left side) and RLA (right side) rats during sexual activity 
Columns and bars indicate the means ± SEM of 12 (naïve) or 10 (experienced) rats per 
group. a: P<0.05 vs the corresponding values of the RLA group; b: P<0.05 vs the time-
matched values of the sexually naïve rats of the same line. IF: inacessible female; C: 
copulation; FR: female removal. 
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3.4 Discussion 
 
In study a, we performed the first systematic characterization of the 
sexual behavior of male RHA and RLA rats (compared, in the study by 
Sanna et al., with SD rats used as a genetically heterogeneous reference 
strain). The main finding emerging from this study is that RHA rats, 
which are impulsive, novelty seekers and proactive copers, show higher 
levels of sexual motivation and a better copulatory performance than their 
RLA counterparts, which are hyperemotional, anxious and reactive 
copers. These line-related differences are more marked when the animals 
are exposed to a receptive female for the first time and tend to decrease 
with repeated copulation tests. A plausible explanation for the attenuation 
of such differences is that RLA rats may engage more readily in sexual 
activity when the effect of novelty is overcome by repeated sexual 
experience. Nonetheless, RLA rats never reach the levels of their RHA 
counterparts, either in terms of percentage of animals engaging in sexual 
activity or in terms of individual behavioral parameters. Moreover, some 
differences (e.g., in copulatory efficacy) remain significant until the last 
test. This finding suggests that, beyond the inhibitory effect of novelty, 
which can be considered as a stressor, additional factors may play a 
relevant role in the behavioral differences between the Roman lines.  
Concerning the appetitive aspects of sexual behavior, in study a the only 
parameter that can be considered as an index of sexual motivation (with a 
negative correlation) is the mount latency ML. Thus, the longer latencies 
shown by RLA vs RHA rats in all five copulation tests indicate a lower 
level of sexual motivation, which was subsequently confirmed using more 
selective behavioral measures in study c. 
The behavioral differences in sexual motivation and performance between 
RHA and RLA rats were confirmed in Study b, which showed for the 
first time that the copulatory pattern of these two lines is differentially 
facilitated by apomorphine and impaired by haloperidol, in keeping with 
the well established facilitatory effect of central DA on sexual behavior  
[159-162, 164, 168, 169]. Thus, in RHA rats, apomorphine induced 
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changes in only a few copulatory parameters and usually at the highest 
dose tested, whereas low doses of apomorphine were sufficient to induce 
a general enhancement of the copulatory performance and sexual 
motivation of RLA rats, so that their sexual behavior approached that of 
RHA rats. Accordingly, in RHA rats, both doses of haloperidol induced 
only minor changes in most copulatory parameters, whereas in RLA rats 
this treatment further impaired the copulatory performance and sexual 
motivation when given alone, and completely abolished the facilitatory 
effect of apomorphine when given in combination. Thus, both 
apomorphine and haloperidol were more effective in sexually experienced 
RLA than RHA rats, suggesting that RLA rats are more responsive to 
both the stimulation and the blockade of dopamine receptors than RHA 
rats. Taken together, the above findings suggest that the Roman lines 
differ in the functional tone of their mesolimbic dopaminergic 
neurotransmission, in particular that involving D2-like receptors.  
 
The possible involvement of differences in D2-like receptor-mediated 
neurotransmission in the distinct copulatory patterns and in the 
differential effects of apomorphine and haloperidol in RHA and RLA rats 
is supported by two recent findings: (i) the D2-like receptor-mediated 
pro-erectile effect of apomorphine and of the D4 receptor agonist PD 
168,077 is more pronounced in RLA than RHA and SD rats [192]; (ii) a 
lower D2 (auto)receptor availability (measured by dopamine receptor 
binding and mRNA assays) has been found in the substantia nigra/ventral 
tegmental area, caudate putamen and nucleus accumbens of RHA vs. 
RLA rats [185]. Considering the inhibitory effect on DA release played 
by D2 autoreceptors, their lower availability in mesolimbic areas of RHA 
rats may result in a more robust mesolimbic dopaminergic tone as 
compared with their RLA counterparts, which may explain, at least in 
part, many behavioral differences between the two lines, including those 
in sexual behavior. 
 
Therefore, on the bases of the above mentioned studies and of previous 
reports showing a greater increase in the extracellular concentrations of 
DA in the AcbSh of RHA vs RLA rats upon the administration of 
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psychostimulants [87, 180, 187], study c was designed to evaluate the 
DA output in dialysates from AcbSh of sexually naïve and sexually 
experienced RHA and RLA rats during the anticipatory and 
consummatory phases of sexual behavior.  
 
As expected, the results of study c demonstrate that the distinct patterns 
of sexual behavior of  RHA and RLA rats are associated with differential 
changes in the concentrations of extracellular dopamine in the AcbSh, 
with RHA rats showing a greater increase in DA output compared with 
their RLA counterparts. Although more evident in sexually naïve rats, 
these differences in mesolimbic dopaminergic activity persist after 
acquisition of a stable baseline level of sexual activity. Interestingly, as 
observed for behavioral patterns, sexual experience has differential effects 
in the two lines. Thus, in RLA rats, sexual experience determines a 
significant increment in the overall DA content compared with the naïve 
condition, whereas, in the RHA line, the accumbal DA output increases 
earlier in sexually experienced than in sexually naïve rats. Moreover, 
while in study a we used a classical paradigm of copulation test in which 
the female was always accessible to the male and the only parameter used 
to assess the sexual motivation was the mount latency, in study c we 
introduced an anticipatory phase in which the female was inaccessible in 
order to better investigate the appetitive aspects of sexual activity. Thus, 
the larger number of non contact erections displayed by RHA vs RLA rats 
in the anticipatory phase associated with time-matched increments of 
accumbal DA output, confirm the higher levels of sexual motivation of 
RHA rats and the role of DA in the appetitive aspects of sexual behavior. 
In this regard, considerable experimental evidence indicates that in the 
mesolimbic brain areas, which include the VTA and the Acb, dopamine 
plays a key role in the control of the appetitive aspects of sexual activity 
(i.e., sexual arousal and motivation) in laboratory animals and in humans 
[164, 165, 167-169]. However, other brain areas are also involved in the 
dopaminergic control of sexual behavior, such as the medial preoptic area 
and paraventricular nucleus of the hypothalamus in which dopamine not 
only drives the consummatory aspects of sexual behavior such as penile 
erection, copulation and ejaculation (i.e., sexual performance), but also 
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participates in the control of sexual motivation via interaction with D2-
like receptors [156, 158, 159, 166, 168, 169, 198]. Whether line-related 
differences like those described above also occur in the dopaminergic 
neurons innervating the medial preoptic area and the paraventricular 
nucleus of the hypothalamus remains unknown and warrants further 
investigation. 
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4. Study III: Differential effects of social 
isolation on inbred Roman high-(RHA-I) 
and low-(RLA-I) avoidance rats 
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4.1 Introduction 
 
Clinical and preclinical studies demonstrate that the exposure to adverse 
experiences in early-life deeply affects brain development and may 
contribute to the occurrence of psychiatric disorders, such as depression, 
schizophrenia, and substance abuse in genetically predisposed individuals 
[170-172]. Although the molecular mechanisms underlying the long-term 
consequences on mental health elicited by adverse events in early-life are 
not yet completely understood, there is experimental evidence supporting 
the involvement of a disruption of the normal development of neural 
systems that control stress responses and emotionality [199]. 
 
Post-weaning social isolation of rodents is an experimental paradigm that 
models some of the behavioral consequences of adverse early-life 
experiences in humans [170-172, 200]. Several reports indicate that 
rearing rodents in persistent social isolation from weaning produces long-
lasting behavioral alterations, such as excessive reactivity to handling, 
aggressive and anxious behaviors, hyperactivity, neophobia, impaired 
sensorimotor gating and cognitive rigidity ([172] and references therein). 
The behavioral repertoire displayed by isolated rats has been defined as 
"isolation-induced stress syndrome" [201, 202] and is accompanied by 
neurochemical and morphological alterations, such as reduced prefrontal 
cortical volume, decreased cortical and hippocampal synaptic plasticity, 
hyperfunction of mesolimbic dopaminergic systems, and other 
dysfunctions in the monoaminergic systems [172]. Collectively, these 
abnormalities resemble core features of schizophrenia and provide 
translational relevance to the social isolation model. Hence, the use of 
psychogenetically selected lines/strains of rats with phenotypic traits 
resembling cardinal symptoms of schizophrenia, may be a valid 
experimental approach to study the complex interaction between genetic 
and environmental factors (such as adverse early-life experiences) in the 
development of the schizophrenic disorder. 
The Roman high avoidance rats, either outbred (RHA) or inbred (RHA-I) 
represent one such model, inasmuch as they show: (i) enhanced impulsive 
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behaviors [99, 100, 125], (ii) relative deficits in latent inhibition threshold 
[126], as well as in PPI and spatial working and reference memory [127, 
128], (iii) enhanced locomotion and mesolimbic dopaminergic 
sensitization in response to the repeated administration of 
psychostimulants [115, 120, 121], (iv) augmented mesocortical 
dopaminergic response to stress [21], and (v) increased stereotypic 
response to the dopamine agonist apomorphine [191, 192]. Conversely, 
RLA/RLA-I rats display higher levels of anxiety/ fearfulness [86, 88, 105, 
203-206], no sensitization upon chronic administration of 
psychostimulants [115, 120, 121], a normal PPI and better performances 
in learning/memory tasks [127, 128]. 
Therefore, the aim of this study was to evaluate the impact of post-
weaning social isolation on anxiety-related behaviors in the Elevated Zero 
Maze and on locomotor activity in a new environment  (motility cages) in 
the Roman inbred strains.  
 
 
 
4.2 Materials and methods 
 
4.2.1 Animals 
A total number of 76 male inbred rats (36 RHA-I and 40 RLA-I) from the 
colony of the Autonomous University of Barcelona were used. At 
postnatal day 20-22 the animals were randomly housed in pairs (12 RHA-
I rats and 16 RLA-I rats) or isolated in individual cages (24 rats of each 
strain). All the rats were maintained in the same room, with a 12 h light-
dark cycle (lights on at 08:00 a.m.), in a temperature (22 ± 2°C) and 
humidity (50–70%) controlled environment. Standard laboratory rat chow 
and water were available ad libitum. The Elevated Zero Maze 
experiments were performed at 16 weeks of isolation, whereas the 
Locomotor Activity was assessed two weeks later (18 weeks of isolation). 
All the experimental procedures were performed in the housing facilities 
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of the Department of Psychiatry and Forensic Medicine of the 
Autonomous University of Barcelona and were approved by the 
committee of Ethics of the Autonomous University of Barcelona in 
accordance with the European Community Council Directive 
(86/609/EEC) regarding the care and use of animals for experimental 
procedures. 
 
4.2.2 Elevated Zero Maze 
The Elevated Zero Maze  (EZM) is a circular corridor elevated above the 
floor and provided with two open quadrants and two closed quadrants. It 
is a variation of the elevated plus maze (EPM), which is a cross-shaped 
maze with two open arms and two closed arms. Both mazes are used to 
assess anxiety-like behavior in small laboratory animals (rats/mice), since 
they are based on two conflicting innate tendencies of the animal: 
exploring a novel environment and avoiding elevated and open spaces 
(that constitute situations of predator risk). When anxious, the animal 
tends to prefer enclosed dark spaces, which represent the security, to open 
brightly lit spaces. In this context, anxiety related behavior is measured by 
the degree to which the animal avoids the open spaces. The advantage of 
the EZM versus the EPM is the lack of an ambiguous central area.  
The EZM used for this study was made of black plywood (105 cm 
diameter and 10 cm width) and was placed 65 cm above the ground level. 
The closed quadrants were delimited by 40 cm high walls. The test started 
by introducing the animal in a closed quadrant of the maze with the snout 
oriented towards the walls and lasted 5 min.  
 
4.2.3 Behavioral measurements 
The following behaviors were quantified by a single well-trained 
observer:  
 latency to enter in an open space (the time elapsed between the 
introduction of the animal in the maze and the first entry in an 
open quadrant); 
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 time spent in open space (the sum of each time spent in open 
quadrants); 
 entries in open space (the number of entries in the open 
quadrants); 
 head dipping (i.e., when the animal sticks out the maze to look 
down and the observer cannot see its nose and eyes; it can be 
considered as a measure of exploration and risk-propensity); 
 SAP (Stretched Attend Posture: a forward elongation of the body 
with a subsequent coming back; it reflects an approach-avoiding 
conflict); 
 crossings (each time in which the animal crosses the virtual lines 
that divide the circle in 4 quadrants and 8 hemiquadrants). 
The trials were videotaped and the behavioral measures were recorded 
outside the test room in order to avoid any interference with the 
performance of the animals. The videotaped behavioral activity was 
assessed at a later time. 
 
4.2.4 Locomotor activity 
In each session, three animals were tested simultaneously using one rat 
for each experimental condition and changing the activity cage assigned 
to each experimental group according to a counterbalanced schedule. The 
test started by placing the animal in the center of a plexiglass activity cage 
(40x40x40) equipped with photocell beams and interfaced by a computer 
software (PanLab) that recorded the horizontal locomotor activity, 
measured as photocell beam breaks, and divided the 30 minutes of the test 
in 6 intervals of 5 minutes.  
 
4.2.5 Data analysis 
Elevated Zero Maze For each behavioral parameter, two-way ANOVA 
with strain (RHA-I and RLA-I) and treatment (isolation or control) as 
between-groups factors was performed. Whenever appropriate (i.e., P for 
the main factors and/or their interaction <0,05), ANOVA was followed by 
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post-hoc pair wise contrasts with the Student's t-test. Further analysis with 
one-way ANOVAs for each strain was used to compare the two groups 
for some of the behavioral parameters. 
Locomotor activity The time course of the locomotor activity was 
evaluated by repeated measures ANOVA with the time intervals (6 
intervals of 5 minutes each) as a within-groups factor and strain and 
treatment as between-groups factors. Further analyses with repeated 
measures ANOVA for each strain and ANOVAs for each interval were 
performed. One-way ANOVAs for each strain was used to evaluate the 
effect of treatment on the total distance travelled. 
 
 
4.3 Results 
 
4.3.1 Elevated Zero Maze 
Latency to enter in open space (Fig. 1) The latency to enter in the open 
space of the control RHA-I rats was significantly shorter than that of their 
RLA-I counterparts. Two-way ANOVA with strain and treatment as 
between-group factors revealed a significant “strain” x “treatment” 
interaction (F (1,72) = 4.00; P = 0.049) but post-hoc contrasts did not 
reveal significant differences due to the treatment. However, analyzing 
both strains separately with ANOVAs, we found a significant effect of 
isolation in RHA-I rats (F(1,34) = 5.05; P<0.031) indicating that 
isolation-reared RHA-I rats delayed their entry to the open spaces of the 
maze. Conversely, no differences between treatments were found in RLA-
I rats. 
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Fig.1 Latency to enter in open space  Columns and bars indicate the means ± SEM of 
48 isolated (24 per line) and 28 group-housed (16 RLA; 12 RHA) rats. *: P<0.05 vs 
RLA-control. 
 
Time spent in open space (Fig. 2) Control RHA-I rats spent significantly 
more time in the open space compared with RLA-I controls. However, 
after prolonged social isolation, the time spent in open space by RHA rats 
was significantly reduced (P<0.001) becoming similar to that of RLA 
rats. On the contrary, no significant differences were found between 
isolated and group-housed RLA-I rats. 
 
 
 
 
 
 
 
 
 
 
 
Fig.2 Time spent in open space  Columns and bars indicate the means ± SEM of 48 
isolated (24 per line) and 28 group-housed (16 RLA; 12 RHA) rats. *: P<0.05 vs RLA-
control; #: P<0.001 vs RHA-control. 
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Entries in open space (Fig 3) The number of entries in open space was 
significantly larger in RHA-I vs RLA-I group-housed rats. Analyzing 
both strains separately, a significant reduction in the number of entries in 
open space was observed in RHA-I isolated rats (F (1,34) = 4.17;  P = 
0.05), whereas isolation did not affect the entries in open space of RLA-I 
isolated rats . 
 
 
 
 
 
 
 
 
 
 
Fig.3 Entries in open space  Columns and bars indicate the means ± SEM of 48 isolated 
(24 per line) and 28 group-housed (16 RLA; 12 RHA) rats. *: P<0.05 vs RLA-control. 
 
Head dipping (Fig 4) In keeping with their high levels of impulsivity, the 
frequency of head dips (considered as an index of exploration and risk-
propensity) displayed by RHA-I controls was significantly higher than 
that of their RLA-I counterparts. Moreover, isolation significantly 
reduced the number of head dips only in RHA-I rats. 
 
 
 
 
 
 
 
 
 
Fig. 4 Head dipping  Columns and bars indicate the means ± SEM of 48 isolated (24 
per line) and 28 group-housed (16 RLA; 12 RHA) rats. *: P<0.05 vs RLA-control; #: 
P<0.001 vs RHA-control. 
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SAPs (Fig 5) No strain- or treatment-dependent effects were detected in 
the frequency of SAPs, probably because of the high variability of the 
experimental groups. 
 
 
 
 
 
 
Fig.5 Stretched Attend Postures Columns and bars indicate the means ± SEM of 48 
isolated (24 per line) and 28 group-housed (16 RLA; 12 RHA) rats. 
Crossings (Fig 6) Statistical evaluation of the frequency of line crossings 
by means of two-way ANOVA revealed a significant “strain” effect (F (1, 
72) = 10.27; P = 0.002) and post hoc contrasts showed that the frequency 
of line crossings was significantly higher in RHA-I controls than in their 
RLA-I counterparts. However, no significant effect of isolation was 
revealed by independent ANOVAs for either strain.  
 
 
 
 
 
 
 
 
 
 
Fig.6 Crossings  Columns and bars indicate the means ± SEM of 48 isolated (24 per 
line) and 28 group-housed (16 RLA; 12 RHA) rats. *: P<0.05 vs RLA-control. 
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4.3.2 Locomotor Activity 
Repeated measures ANOVA, with strain and treatment as between-groups 
factors  and six time intervals (of 5 minutes each) as within-groups factor,  
revealed a significant "strain" x "interval" interaction (F(5,360) = 2.73 P = 
0.020) (Fig.7). Both main effects were also significant (F (1, 72) = 7.21 P 
= 0.009 for strain and F (1, 72) = 4.58 p = 0.036 for treatment) but not the 
"strain" x "treatment" interaction. Independent repeated measures 
ANOVAs for each strain revealed a significant effect of the isolation in 
RHA-I rats (F (1, 32) = 8.89 P = 0.005), indicating that RHA-I rats reared 
in isolation travelled longer distances during the 30-min session (Fig. 8). 
Moreover,  independent ANOVAs for each interval in RHA-I rats showed 
significant differences in 4 out of  6 intervals (1
st
, 3
rd
, 5
th
 and 6
th
), 
indicating an increment of the locomotor activity in isolated vs control 
RHA-I rats ( Fs (1, 34) ≥ 4.34 p ≤ 0.045) (Fig.7).   
 
 
 
 
 
 
 
 
Fig. 7 Time course of locomotor activity. Shown are the means ± S.E.M. of the 
distances travelled in each 5-minutes interval by RLA-I (left-hand panel) and RHA-I 
(right-hand panel) control and isolated rats. *:P<0.045 vs the line-matched control 
group. 
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Fig.8  Total distance travelled Columns and bars indicate the mean ± S.E.M. of the 
total distance travelled by RLA-I (left-hand panel) and RHA-I (right-hand panel) control 
and isolated rats.  *: P< 0.05 vs the line-matched control group. 
 
 
4.4 Discussion 
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dangerous behavior that reflects the risk propensity of the animal. In 
keeping with their high levels of impulsivity, RHA controls display a 
significantly higher HD frequency than RLA controls. Notably, social 
isolation makes RHA rats more cautious as indicated by the significant 
reduction in HD frequency of isolated versus control rats. Also the 
reduction in the number of entries  (EOS) and the increased latency to 
entry in the open space displayed by the isolated RHA rats are indexes of 
increased anxiety. However, the number of EOS is not as important as the 
TOS because a high number of EOS does not necessarily imply that the 
animal spends much time in the open space, but may reflect a continuous 
going out and coming back. Similarly, the number of crossings captures 
locomotor activity rather than anxiety. Collectively, these results show 
that post-weaning social isolation increments the anxiety-related 
behaviors in the EZM paradigm only in RHA-I rats.   
 
In order to test whether the results obtained with the EZM were due to 
non-specific effects on locomotor activity in a new environment, we used 
motility cages to valuate more directly this behavioral measure. The 
results obtained show that post-weaning social isolation increases 
locomotor activity only in RHA-I rats. The hyperactivity in a new 
environment displayed by isolated RHA-I rats argues against the 
possibility that their behavior in the EZM (i.e., increased latency to enter 
in open space, reduced TOS and EOS) may be due to a non-specific 
impairment of the locomotor activity. 
 
The results obtained in the Elevated Zero Maze and the assessment of 
Locomotor Activity in a new environment are consistent with the large 
number of previous studies in the Roman strains/lines showing that, under 
basal conditions, RHA-I/RHA rats are less anxious and more prone to 
explore and eventually risk than RLA-I/RLA rats. Moreover, compared 
with their RLA-I/RLA counterparts, RHA-I/RHA rats display higher 
levels of horizontal activity in a new environment, in keeping with their 
marked profile of sensation/novelty seekers.   
In addition, this study shows that the isolation-rearing procedure 
significantly increases the levels of anxiety in the EZM and the novelty-
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induced locomotor activity only in RHA-I rats, suggesting a higher 
vulnerability of this strain (compared with its RLA-I counterpart) to some 
effects of social isolation. In this context, it is interesting to note that 
RHA-I rats reared in isolation displayed an excessive reaction to handling 
which, combined with the increased anxiety and the hyperactivity, 
contributes to delineate the behavioral features of the so-called "isolation 
stress-induced syndrome".  
 
These results are in line with previous studies describing the same effects 
of social isolation ([199] and references therein) and with our pilot 
experiments using inbred Roman rats showing behavioral alterations 
resembling core features of schizophrenia, such as PPI deficits and 
cognitive impairments in long term spatial reference memory that are 
displayed exclusively by isolated RHA-I rats (Oliveras et al., 
submitted). 
 
In conclusion, these preliminary data add experimental support to the 
view that the Roman strains may be used as a valid genetic model to 
investigate the neural underpinnings of the vulnerability (RHA-I) and the 
resistance (RLA-I) to develop schizophrenia-relevant symptoms upon 
isolation rearing.  
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5. General discussions 
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5.1 Brief summary of results 
 
Study I: In RLA rats, which display robust depression-like behaviors in 
the forced swim test (FST), chronic treatments with low doses of 
antidepressants, that were ineffective when given subacutely, decreased 
immobility and also increased climbing (desipramine) or swimming 
(fluoxetine). Conversely, neither subacute nor chronic antidepressant 
treatments affected the behavior of RHA rats in the FST. 
Study II: Compared with their RLA counterparts, RHA rats showed 
higher levels of sexual motivation and a better copulatory performance, 
associated with a greater release of DA in the AcbSh.  These line-related 
differences were attenuated but not abolished by sexual experience. 
Moreover, RLA rats were more responsive to both, the facilitatory effect 
of apomorphine and the inhibitory effect of haloperidol on sexual 
behavior. 
Study III: In RHA-I rats, the isolation-rearing procedure significantly 
increased the levels of anxiety in the EZM as indicated by a reduction in 
the number of entries and time spent in the open space, decreased head 
dipping, and increased latency to enter in open space, and increased the 
novelty-induced locomotor activity. In contrast, isolation-rearing failed to 
produce significant changes in the behavior of RLA-I rats. 
 
5.2.1 Roman rats as genetic animal models of 
psychiatric disorders  
Ideally, in order to have translational valence, an animal model should 
mimic the human condition of interest with respect to its 
etiology/biological basis (construct validity), symptomatology (face 
validity) and treatment (predictive validity) [65]. 
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The etiological validation of a model, that is, of its construct validity, is a 
fundamental aspect of scientific investigation.  This implies a basic 
knowledge of the etiology of the condition we want to model. 
Unfortunately, the etiologies of psychiatric disorders are still poorly 
understood. Hence, construct validity in this context is generally limited 
to hypotheses regarding a plausible etiology. Indeed, the purpose of the 
development of animal models is often to enable the identification of the 
etiology of the disease [207].  
 
5.2.1 Vulnerability (RLA) and resistance (RHA) to stress-
induced depression 
It is well established that depression is a highly heritable disorder, with 
genetic factors comprising roughly 50% of the risk for depression. 
Genetic factors contribute to determine the animal's responses to stress, 
which is one of the most important environmental risk factors for 
depression, and they influence also the response to antidepressant 
treatments [208]. Most rodent models of depression are based on the 
exposure to stress of normal, healthy animals, thereby ignoring the 
genetic-based vulnerability.  
A valid approach to study the complex interaction between genetic 
predisposition and environmental factors in the etiopathogenesis of 
depression may be represented by the selective breeding of animals with 
marked differences in depression-like phenotypes [209-211]. For 
instance, selective breeding has been applied to the forced swim test to 
select animals for high (SwHi) or low (SwLo) levels of swimming 
activity. The Swim Low Active line shows an innate low swimming 
activity that is increased after antidepressant administration [212]. A 
similar innate behavior is displayed also by the Flinders Sensitive line 
[74] and the Wistar Kyoto rats [213] (both selected for modeling 
conditions different from depression), that have been proposed as genetic 
models of depression. 
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In this context, the results obtained in study I  are in line with the 
findings derived from other genetically selected lines or strains of rats. 
Moreover, the passive strategy adopted by RLA rats in the FST can be 
defined as a heritable trait, since it was consistently reproduced along the 
six generations of Roman rats used for these studies.  
Notably, study I also shows the predictive validity of the Roman Low 
Avoidance rats as a model of stress-induced depression-like phenotype, 
since RLA rats positively respond to chronic antidepressant drugs that are 
clinically effective. Conversely, RHA rats do not develop depression-like 
behavior in the forced swim test and, consequently, are not responsive to 
subacute or chronic antidepressant treatments. The results obtained in 
RHA rats are as important as those reported in RLA rats, since they 
suggest that the phenotypic traits of RHA rats may be involved in their 
resistance to display stress-induced depression-like behaviour.  
Notably, RHA and RLA rats markedly differ in their capability to cope 
with stressful events, which is considered to play an important role in 
determining vulnerability to stress-induced depression and post-traumatic 
stress disorders [72, 214, 215]. Thus, RLA rats show a reactive coping 
associated with an elevated HPA axis reactivity which may explain, at 
least in part, their vulnerability to display stress-induced depression-like 
behaviour. In contrast, the proactive coping  displayed by RHA rats 
associated with low-intensity HPA axis responses may account for their 
resistance to stress-induced depression [21, 86, 88, 181, 216, 217].  
 
5.2.2 The role of dopamine 
Considerable experimental evidence supports the role of the central 
dopaminergic system in depression and other stress-related psychiatric 
disorders [218, 219]. In this context, it is interesting to note that the 
coping style of the Roman lines/strains of rats is related to their prefrontal 
dopaminergic function. Thus, when exposed to aversive stimuli, RHA, 
but not RLA, rats show a marked increase in dopamine output in the 
prefrontal cortex [21, 114]. This finding is in line with the view that the 
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mesocortical dopaminergic projection is critically involved in the 
concerted execution of the motor activities that define a coping strategy 
[112, 113].  
Such differences in dopamine transmission may also be involved in the 
lower levels of immobility and the more robust climbing activity 
displayed under baseline conditions by RHA rats as compared with their 
RLA counterparts. Thus, compounds that enhance dopaminergic 
transmission are known to increase climbing in the forced swim test 
[179], whereas a mesocortical dopaminergic hypofunction may be 
involved in the psychomotor retardation observed  in some depressed 
patients [19]. 
The dopamine-related differences between the two lines are also extended 
to the mesolimbic transmission. Thus, the responsiveness of the 
mesolimbic dopaminergic system to natural and drug rewards is 
significantly higher in RHA than in RLA rats, as demonstrated by several 
studies in inbred [220] and outbred Roman rats [87, 115, 116, 180, 221], 
and by the results obtained in study II. 
 
5.2.3 Processing of rewarding stimuli in depression and 
other psychiatric disorders 
Study II shows that the Roman lines also differ in sexual behavior, one of 
the main sources of natural reward, with RHA rats showing higher sexual 
motivation and better copulatory performance than RLA rats. These 
findings were obtained using classical copulation tests as well as in the 
presence of an inaccessible receptive female, where RHA rats show more 
non contact erections than RLA rats. Since non contact erections are 
considered as an index of sexual arousal, their higher occurrence in RHA 
vs RLA rats is an additional confirmation of the greater sexual motivation 
displayed by RHA rats.  
It is noteworthy in this context that depression is typically linked to 
motivational anhedonia (i.e., the loss of interest in once pleasurable 
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activities, including sex) which has been consistently correlated with 
impaired mesolimbic dopaminergic signalling [138, 139].   
Notably, the distinct sexual behavioral patterns of RHA and RLA rats, 
both, in the presence of an inacessible female and during copulation, are 
related with differential changes in the concentrations of extracellular 
dopamine in the nucleus accumbens shell. 
Thus, the larger increases in extracellular dopamine that occur in the shell 
of sexually naïve and experienced RHA versus RLA rats during sexual 
activity support the role of mesolimbic dopamine in sexual behavior [164-
168] and are consistent with the results of previous studies  showing that a 
higher dopamine release occurs in NAcSh of RHA versus RLA rats upon 
the administration of drugs that increase mesolimbic dopaminergic 
transmission [87, 180, 185, 222].  
Importantly, both RLA and RHA rats seem to display a dysfunction in 
processing rewarding stimuli, which is a key feature of some psychiatric 
conditions: on the one hand, RLA rats show a lack of motivation 
resembling the anhedonia observed in many depressed patients. On the 
other hand, RHA rats display an excessive activation of the mesolimbic 
dopaminergic system that promotes incentive learning, which is 
considered to be critically involved in substance abuse disorders.  
 
5.2.4 Early life stress and psychiatric disorders: the 
contribution of Roman rats 
One of the predisposing factors for the development of psychiatric 
disorders is the exposure to adverse experiences in early-life [172, 199]. 
Stress, including early life stress, may interact with genetically 
determined vulnerabilities to modify behavioral phenotypes [208]. 
Accordingly, in study III we found that the hypoemotional and novelty 
seekers RHA-I rats became anxious and fearful after prolonged isolation 
rearing (IR), whereas such early life stress did not affect the behavior of 
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RLA-I rats. Likewise, the IR-induced hyperactivity is observed only in 
RHA-I rats, suggesting a higher vulnerability of this strain (compared 
with its RLA-I counterpart) to some effects of social isolation. 
Interestingly, the results of study III, combined with other promising 
results obtained in the Spanish colony of Roman inbred rats (see 
discussion of study III), suggest that post weaning social isolation may 
contribute to the occurrence of schizophrenia-like symptoms in the 
genetically predisposed RHA rats.  
Notably, whereas early adverse experiences may negatively affect brain 
development thereby leading to psychiatric disorders, positive 
environmental experiences are able to modulate complex behavior and 
eventually compensate for gene-dependent abnormalities. In this context, 
it is noteworthy that neonatal handling reduces most behavioral and 
physiological signs of emotionality/anxiety in RLA/Verh rats, including 
an improvement in the performance in the two-way active avoidance test, 
while environmental enrichment increases their novelty seeking, 
saccharin and ethanol intake, and sensitivity to amphetamine. 
Additionally, both treatments seem to have a sort of "protective" effect 
against some age-related deficits [123, 206, 223-226].   
 
5.3 Future directions 
Interestingly, recent western blot and immunohistochemistry studies 
performed in collaboration with Quartu and colleagues (in preparation) 
have shown that, under baseline conditions, the expression of BDNF and 
its receptor trkB is significantly lower in the hippocampus of outbred 
male RLA rats compared with their RHA counterparts. This result is in 
line with previous studies showing that the availability and/or 
responsiveness to BDNF are reduced in the hippocampus of depressed 
patients and of experimental animals exposed to acute or chronic stressful 
conditions [35]. Accordingly, chronic administration of corticosterone 
reduces BDNF expression in the rat hippocampus [46], suggesting that 
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the effects of stress on hippocampal neurons are mediated by 
glucocorticoids. 
It is noteworthy in this context that a large percentage of depressed 
patients shows sustained high levels of glucorticoids which lead to an 
impairment of the inhibitory feedback on the HPA axis [25] with a 
consequent damage of hippocampal neurons due to the enhanced activity 
of the HPA axis [26, 27]. Moreover, the neuronal damage triggers a 
positive feedback because the reduction in the inhibitory control exerted 
by the hippocampus on the HPA axis leads to a further increase in 
circulating glucocorticoid levels and subsequent hippocampal damage [2]. 
In keeping with findings in depressed patients, when exposed to stressful 
conditions RLA rats display higher levels of corticosterone with respect 
to their RHA counterparts, and a concomitant reduction of the inhibitory 
feedback on the HPA axis [104, 106, 108].  
The large increment in the levels of corticosterone shown by RLA rats in 
response to stress may induce a reduction in the expression of BDNF in 
the hippocampus thereby leading to a disruption of hippocampal function, 
impairment of the corticosterone-mediated inhibitory feedback and 
hyperactivation of the HPA axis. The persistence of such cascade of 
events may account, at least in part, for the depressive-like behavior 
displayed by RLA rats. Alternatively, it may be posited that the lower 
basal levels of BDNF and trkB in the hippocampus of RLA rats as 
compared with that of RHA rats may sensitize the hippocampal neurons 
to the negative effects exerted by glucocorticoids. 
Hence, experiments are in progress in our laboratory aimed at assessing 
the expression of neutrophic factors and their receptors, as well as of pre- 
and post-synaptic proteins in the hippocampus and other brain areas of the 
Roman lines in response to acute and chronic stress, with and without 
combined antidepressant treatments.  
Moreover, neurotrophic factors and synaptic proteins are known to play a 
pivotal role in learning and memory. Therefore, since learning processes 
are critically involved in the modifications in copulatory performance 
observed in sexually experienced animals as compared with their sexually 
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naïve counterparts, future studies will be devoted to the characterization 
of the plastic changes that occur during the acquisition of sexual 
experience in brain areas involved in learning and memory, such as the 
hippocampus and other limbic areas that are a part of the so called 
"reward circuit", including the ventral tegmental area, the amygdala, the 
nucleus accumbens and the medial prefrontal cortex. 
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6. Conclusions 
 
In conclusion, the results of these studies have shown that the Roman 
lines/strains of rats may provide a valid experimental approach to study: 
 alterations in the neural substrates and mechanisms involved in the 
individual vulnerability and resistance to stress-induced 
depression, with the aim of identifying potential biomarkers for an 
early diagnosis of depression, and molecular targets for new 
antidepressant treatments; 
 the neurophysiology of sexual function (in its appetitive and 
consummatory aspects), in order to better understand the 
mechanisms underlying the psychopathological and 
pharmacologic causes of sexual dysfunctions; 
 the ways in which early-life adverse (or positive) experiences may 
interact with the genetically determined vulnerability to develop 
psychiatric disorders. 
The pathogenesis of depression, as well as the mechanisms of action of 
antidepressants, but also the learning processes involved in the acquisition 
of sexual experience, and the consolidation of memories of either aversive 
or rewarding experiences, involve the ability of the nervous system to 
reorganize its structure, function and connections in response to internal 
and external stimuli. Such ability is defined as neuroplasticity.  
RHA and RLA rats, which differ markedly in their responses to stress 
(including early life stress) and to rewarding stimuli (including sexual 
activity), may therefore be used to investigate the neuroplastic changes 
(i.e., expression of neurotrophic factors, intracellular signaling cascades, 
epigenetic modifications, etc.) induced by environmental factors that 
occur during sexual learning, and during the development and therapy of 
psychiatric disorders.  
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